Publications

Here are the scientific works from the Bandim Health Project.  

You can also download the list of publications as a PDF-file.

Click here to download the file.


  1. Aaby P, Benn CS. Syvfold fald i børnedødeligheden i Guinea-Bissau de seneste 40 år. Ugeskrift for Læger/Dan Med J 2018.

  2. Whittle H, Aaby P. Measles.  Oxford Textbook of Medicine; 2018.

  3. Welega P. Evaluation of the non-specific effects of routine vaccines (BCG, DTP and measles) on child survival in Northern Ghana. Odense: Southern Danish University; 2018.

  4. Welaga P, Hodgson A, Debpuur C, Aaby P, Binka F, Azongo D, et al. Measles Vaccination Supports Millennium Development Goal 4: Increasing Coverage and Increasing Child Survival in Northern Ghana, 1996-2012. Front Public Health 2018; 6: 28.

  5. Wejse C, Hønge BL. Time to revise the notion that HIV-2 is benign and not a major global health problem? Invited commentary. Lancet HIV 2018.

  6. Ugolini M, Gerhard J, Burkert S, Jensen KJ, Georg P, Ebner F, et al. Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses. Nat Immunol 2018; 19(4): 386-96.

  7. Thysen SM, Fisker AB, Vaccines Iwgo, Child S. Selecting the right indicators to ensure optimised implementation of BCG vaccination policy. Vaccine 2018; 36(24): 3406-7.

  8. Thostesen LM, Kjaergaard J, Pihl GT, Birk NM, Nissen TN, Aaby P, et al. Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial. Allergy 2018; 73(2): 498-504.

  9. Thomsen D, Erikstrup C, Jespersen S, Medina C, Te DDS, Correira FG, et al. The influence of human leukocyte antigen-types on disease progression among HIV-2 infected patients in Guinea-Bissau. AIDS 2018; 32(6): 721-8.

  10. T. PG, Ammentorp J, Kofoed P-E. Hvordan støtter vi bedst forældre, når de skal beslutte, om deres barn skal vaccineres? . Månedsskrift for almen praksis 2018: 585-195.

  11. Stensballe LG, Ravn H, Birk NM, Kjaergaard J, Nissen TN, Pihl GT, et al. BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial. J Pediatric Infect Dis Soc 2018.

  12. Steiniche D, Jespersen S, Medina C, Sanha FC, Wejse C, Honge BL, et al. Excessive mortality and loss to follow-up among HIV-infected children in Guinea-Bissau, West Africa: a retrospective follow-up study. Trop Med Int Health 2018; 23(10): 1148-56.

  13. Sorup S, Jensen AKG, Aaby P, Benn CS. Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018.

  14. Schoeps A, Nebie E, Fisker AB, Sie A, Zakane A, Muller O, et al. No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial. Vaccine 2018; 36(15): 1965-71.

  15. Schaltz-Buchholzer F, Biering-Sorensen S, Lund N, Monteiro I, Umbasse P, Baerent Fisker A, et al. Early Bacille Calmette-Guerin vaccination, hospitalizations and hospital deaths: Analysis of a secondary outcome in three randomized trials from Guinea-Bissau. J Infect Dis 2018.

  16. Rosentierne M, Buchholzer F, Bruzadelli F, Có A, Cardoso P, Jørgensen C, et al. Microcephaly in Guinea-Bissau – Zika virus or TORCH? Emerging Infectious diseases 2018.

  17. Rasmussen DN, Unger HW, Bjerregaard-Andersen M, da Silva Te D, Vieira N, Oliveira I, et al. Political instability and supply-side barriers undermine the potential for high participation in HIV testing for the prevention of mother-to-child transmission in Guinea-Bissau: A retrospective cross-sectional study. PLoS One 2018; 13(8): e0199819.

  18. Pinstrup Joergensen AS, Bjerregaard-Andersen M, Biering-Sorensen S, Byberg S, Camala L, Martins C, et al. Admission and mortality at the main neonatal intensive care unit in Guinea-Bissau. Trans R Soc Trop Med Hyg 2018; 112(7): 335-41.

  19. Pihl GT, Ammentorp J, Johannessen H, Kjaergaard J, Nissen TN, Birk NM, et al. Mothers' informational needs when deciding to have their newborn infant vaccinated with BCG. A Mixed-methods design. Scand J Caring Sci 2018; 32(3): 1118-26.

  20. Pedersen KB, Holck ME, Jensen AKG, Suppli CH, Benn CS, Krause TG, et al. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers. Scand J Public Health 2018: 1403494818786146.

  21. Olesen JS, Jespersen S, da Silva ZJ, Rodrigues A, Erikstrup C, Aaby P, et al. HIV-2 continues to decrease, whereas HIV-1 is stabilizing in Guinea-Bissau. AIDS 2018; 32(9): 1193-8.

  22. Nissen TN, Birk NM, Blok BA, Arts RJW, Andersen A, Kjaergaard J, et al. Bacillus Calmette-Guerin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial. Eur J Clin Microbiol Infect Dis 2018; 37(1): 29-41.

  23. Nag S, Kofoed PE, Ursing J, Lemvigh CK, Allesoe RL, Rodrigues A, et al. Direct whole-genome sequencing of Plasmodium falciparum specimens from dried erythrocyte spots. Malar J 2018; 17(1): 91.

  24. Mason JB, Benn CS, Sachdev H, West KP, Jr., Palmer AC, Sommer A. Should universal distribution of high dose vitamin A to children cease? BMJ 2018; 360: k927.

  25. Kloprogge F, Workman L, Borrmann S, Tekete M, Lefevre G, Hamed K, et al. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLoS Med 2018; 15(6): e1002579.

  26. Kjerulff B, Honge BL, Olesen JS, Jensen MM, da Silva ZJ, Erikstrup C, et al. Phylogeny of human T-lymphotropic virus-1 subtypes in Guinea-Bissau. Trans R Soc Trop Med Hyg 2018; 112(4): 175-80.

  27. Jespersen S, Rudolf F, Kofoed PE, Wejse C. Behandling af HIV, tuberkulose og malaria i et af verdens fattigste lande. Ugeskr Læger 2018.

  28. Jespersen S, Honge BL, Krarup H, Medstrand P, Sorensen A, Medina C, et al. Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): a Randomised Controlled Trial. J Acquir Immune Defic Syndr 2018.

  29. Hønge BL, Petersen MS, Jespersen S, Medina C, Té DS, Kjerulff B, et al. T and B-cell perturbations identify differences in HIV-2 compared with HIV-1 induced immunodeficiency. AIDS 2018.

  30. Honge BL, Patsche CB, Jensen MM, Schaltz-Buchholzer F, Baad-Hansen T, Wejse C. Case Report: Iatrogenic Infection from Traditional Treatment of Stingray Envenomation. Am J Trop Med Hyg 2018; 98(3): 929-32.

  31. Honge BL, Jespersen S, Medina C, Te DS, da Silva ZJ, Christiansen M, et al. The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections. HIV Med 2018; 19(6): 403-10.

  32. Hansen JS, Thysen SM, Rodrigues A, Martins C, Fisker AB. Is early measles vaccination associated with stronger survival benefits than later measles vaccination? BMC Public Health 2018; 18(1): 984.

  33. Hansen B, al e. Impact of H1N1 influenza vaccination on child morbidity in urban Guinea-Bissau. J Trop Pediatr 2018.

  34. Hanifi SMA, Ravn H, Aaby P, Bhuiya A. Where girls are less likely to be fully vaccinated than boys: Evidence from a rural area in Bangladesh. Vaccine 2018; 36(23): 3323-30.

  35. Hanifi S. Non-specific effects of vaccines and sex-differential child mortality in rural Bangladesh. Odense: Southern Danish University; 2018.

  36. Gronborg HL, Jespersen S, Egedal JH, Correia FG, Medina C, Krarup H, et al. Prevalence and clinical characteristics of CMV coinfection among HIV infected individuals in Guinea-Bissau: a cross-sectional study. Trop Med Int Health 2018; 23(8): 896-904.

  37. Funch KM, Thysen SM, Rodrigues A, Martins CL, Aaby P, Benn CS, et al. Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study. Hum Vaccin Immunother 2018: 1-9.

  38. Fisker AB, Thysen SM, Benn CS, Aaby P. Begrænset kendskab til effekten af vaccinationer og A-vitamin tilskud på børnedødeligheden i Afrika. Ugeskr Læger 2018; 22.

  39. Fisker AB, Thysen SM. Non-live pentavalent vaccines after live measles vaccine may increase mortality. Vaccine 2018; 36(41): 6039-42.

  40. Fisker AB, Thysen SM. Implementation and assessment of vaccination programmes: the importance of vaccination sequence for overall health outcomes. Hum Vaccin Immunother 2018: 1-4.

  41. Fisker AB, Nebie E, Schoeps A, Martins C, Rodrigues A, Zakane A, et al. A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018; 66(10): 1573-80.

  42. de Bree LCJ, Koeken V, Joosten LAB, Aaby P, Benn CS, van Crevel R, et al. Non-specific effects of vaccines: Current evidence and potential implications. Semin Immunol 2018.

  43. de Bree C, Marijnissen RJ, Kel JM, Rosendahl Huber SK, Aaby P, Benn CS, et al. Bacillus Calmette-Guerin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice. Front Immunol 2018; 9: 869.

  44. de Bree C, Janssen R, Aaby P, van Crevel R, Joosten LAB, Benn CS, et al. The impact of sex hormones on BCG-induced trained immunity. J Leukoc Biol 2018; 104(3): 573-8.

  45. D T, CJ H, BL H, C M, DdS T, FG C, et al. Prevalence and predictors of cryptococcal antigenemia among HIV infected patients with low CD4 cell count in Guinea-Bissau. Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau. Pan Afr Med J 2018; (29): 18.

  46. CS B, A R, KJ J, P A. The role of maternal priming and boosting for the non-specific effects of BCG vaccine. In The Value of BCG and TNF in Autoimmunity; 2018.

  47. Christiansen M, Erikstrup C, Medina C, Moller BK, Honge BL. Two novel HLA-B alleles, HLA-B*53:01:17 and -B*58:83, found in patients from Guinea-Bissau. HLA 2018.

  48. Brond M, Martins CL, Byberg S, Benn CS, Whittle H, Garly ML, et al. Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age. J Pediatric Infect Dis Soc 2018; 7(3): 226-33.

  49. Blok B, Jensen KJ, Aaby P, Fomsgaard A, van Crevel R, Benn CS, et al. Opposite effects of Vaccinia and Modified Vaccinia Ankara on trained immunity. European Journal of Clinical Microbiology & Infectious Diseases 2018.

  50. Bjerregaard-Andersen M, Lund N, Pinstrup Joergensen AS, Starup Jepsen F, Werner Unger H, Mane M, et al. Stillbirths in urban Guinea-Bissau: A hospital- and community-based study. PLoS One 2018; 13(5): e0197680.

  51. Biering-Sorensen S, Jensen KJ, Monterio I, Ravn H, Aaby P, Benn CS. Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials. J Infect Dis 2018; 217(5): 759-66.

  52. Benn CS, Aaby P, Sørup S. Uspecifikke effekter af vaccination i Danmark. Ugeskr Læger 2018.

  53. Benn CS, Fisker AB, Wieringa FT, Coutsoudis A, Sachdev HPS. Vitamin A distribution in danger: should we worry? The Lancet 2018; 392(10148): 631.

  54. Benn CS, Fisker AB, Rieckmann A, Jensen AKG, Aaby P. How to evaluate potential non-specific effects of vaccines: the quest for randomized trials or time for triangulation? Expert Rev Vaccines 2018; 17(5): 411-20.

  55. Baschieri A, Gordeev VA, Akuze J, Kwesiga D, Blencowe H, Cousens S, et al. Every Newborn-INDEPTH” (EN-INDEPTH) study protocol for a randomised comparison of household survey modules for measuring pregnancy outcomes in five Health and Demographic Surveillance sites. J Glob Health 2018.

  56. B H. HIV-1, HIV-2 and HIV-1/2 dual infections in Guinea-Bissau, West Africa: HIV type discrimination and immunological differences: Århus University; 2018.

  57. Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe 2018; 23(1): 89-100 e5.

  58. Andersen MN, Honge BL, Jespersen S, Medina C, da Silva Te D, Laursen A, et al. Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in Human Immunodeficiency Virus Infection. J Infect Dis 2018; 218(8): 1291-5.

  59. Andersen A, Fisker AB, Rodrigues A, Martins C, Ravn H, Lund N, et al. National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials. Front Public Health 2018; 6: 13.

  60. Aaby P, Benn CS. Beneficial Nonspecific Effects of Oral Polio Vaccine (OPV): Implications for the Cessation of OPV? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; 65(3): 420-1.

  61. Aaby P, Andersen A, Ravn H, Zaman K. Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural Bangladesh. EBioMedicine 2017; 22: 173-80.

  62. Welaga P, Oduro A, Debpuur C, Aaby P, Ravn H, Andersen A, et al. Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana. Vaccine 2017; 35(18): 2496-503.

  63. Vieira N, Rasmussen DN, Oliveira I, Gomes A, Aaby P, Wejse C, et al. Awareness, attitudes and perceptions regarding HIV and PMTCT amongst pregnant women in Guinea-Bissau- a qualitative study. BMC Womens Health 2017; 17(1): 71.

  64. Thostesen LM, Stensballe LG, Pihl GT, Kjaergaard J, Birk NM, Nissen TN, et al. Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trial. J Allergy Clin Immunol 2017; 140(6): 1616-21 e3.

  65. Thostesen LM, Kjaer HF, Pihl GT, Nissen TN, Birk NM, Kjaergaard J, et al. Neonatal BCG has no effect on allergic sensitization and suspected food allergy until 13 months. Pediatr Allergy Immunol 2017; 28(6): 588-96.

  66. Thomsen D, Hviid CJ, Hønge BL, Medina C, Te D, Correira FG, et al. Prevalence and predictors of cryptococcal antigenemia among HIV infected patients with low CD4 cell count in Guinea-Bissau. Pan Afr Med J 2017.

  67. Seegert AB, Rudolf F, Wejse C, Neupane D. Tuberculosis and hypertension-a systematic review of the literature. Int J Infect Dis 2017; 56: 54-61.

  68. Schaltz-Buchholzer F, Frankel HN, Benn CS. The real-life number of neonatal doses of Bacille Calmette-Guerin vaccine in a 20-dose vial. Glob Health Action 2017; 10(1): 1-4.

  69. Rudolf F, Wagner AJ, Back FM, Gomes VF, Aaby P, Ostergaard L, et al. Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR. Int J Tuberc Lung Dis 2017; 21(1): 67-72.

  70. Rieckmann A, Villumsen M, Sorup S, Haugaard LK, Ravn H, Roth A, et al. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010. Int J Epidemiol 2017; 46(2): 695-705.

  71. Rieckmann A, Villumsen M, Jensen ML, Ravn H, da Silva ZJ, Sorup S, et al. The Effect of Smallpox and Bacillus Calmette-Guerin Vaccination on the Risk of Human Immunodeficiency Virus-1 Infection in Guinea-Bissau and Denmark. Open Forum Infect Dis 2017; 4(3): ofx130.

  72. Pfeiffer G, Fisker AB, Nebie E, Hengelbrock J, Sie A, Becher H, et al. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso. Vaccine 2017; 35(51): 7114-20.

  73. Patsche CB, Rudolf F, Mogensen SW, Sifna A, Gomes VF, Byberg S, et al. Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau. Int J Tuberc Lung Dis 2017; 21(6): 664-9.

  74. Nordentoft PB, Engell-Sorensen T, Jespersen S, Correia FG, Medina C, da Silva Te D, et al. Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau. Infection 2017; 45(2): 187-97.

  75. Nissen TN, Birk NM, Smits G, Jeppesen DL, Stensballe LG, Netea MG, et al. Bacille Calmette-Guerin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial. Vaccine 2017; 35(16): 2084-91.

  76. Nielsen BU, Byberg S, Aaby P, Rodrigues A, Benn CS, Fisker AB. Seasonal variation in child mortality in rural Guinea-Bissau. Trop Med Int Health 2017; 22(7): 846-56.

  77. Nag S, Dalgaard MD, Kofoed PE, Ursing J, Crespo M, Andersen LO, et al. High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology. Sci Rep 2017; 7(1): 2398.

  78. Mogensen SW, Andersen A, Rodrigues A, Benn CS, Aaby P. The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment. EBioMedicine 2017; 17: 192-8.

  79. Mero S, Kirveskari J, Antikainen J, Ursing J, Rombo L, Kofoed PE, et al. Multiplex PCR detection of Cryptosporidium sp, Giardia lamblia and Entamoeba histolytica directly from dried stool samples from Guinea-Bissauan children with diarrhoea. Infect Dis (Lond) 2017; 49(9): 655-63.

  80. Marks F, von Kalckreuth V, Aaby P, Adu-Sarkodie Y, El Tayeb MA, Ali M, et al. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.

  81. Madsen T, Medina C, Jespersen S, Wejse C, Honge BL. Noma in an HIV infected patient in Guinea-Bissau: a case report. Infection 2017; 45(6): 897-901.

  82. Kagone M, Ye M, Nebie E, Sie A, Schoeps A, Becher H, et al. Vaccination coverage and factors associated with adherence to the vaccination schedule in young children of a rural area in Burkina Faso. Glob Health Action 2017; 10(1): 1399749.

  83. Jensen KJ, Sondergaard MJ, Andersen A, Martins C, Erikstrup C, Aaby P, et al. Long-term sex-differential effects of neonatal vitamin A supplementation on in vitro cytokine responses. Br J Nutr 2017; 118(11): 942-8.

  84. Jelenkovic A, Yokoyama Y, Sund R, Pietilainen KH, Hur YM, Willemsen G, et al. Association between birthweight and later body mass index: an individual-based pooled analysis of 27 twin cohorts participating in the CODATwins project. Int J Epidemiol 2017; 46(5): 1488-98.

  85. Hviid CJ, Lund M, Sorensen A, Ellermann-Eriksen S, Jespersen B, Dam MY, et al. Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool. PLoS One 2017; 12(3): e0174012.

  86. Honge BL, Petersen MS, Olesen R, Moller BK, Erikstrup C. Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry. PLoS One 2017; 12(11): e0187440.

  87. Hansen NS, Byberg S, Hervig Jacobsen L, Bjerregaard-Andersen M, Jensen AKG, Martins C, et al. Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau. PLoS One 2017; 12(5): e0177547.

  88. Gronborg HL, Jespersen S, Honge BL, Jensen-Fangel S, Wejse C. Review of cytomegalovirus coinfection in HIV-infected individuals in Africa. Rev Med Virol 2017; 27(1).

  89. Greiner T, Fisker AB. High dose vitamin A capsules – Rusty bullets? World Nutrition 2017; 8(1): 52.

  90. Do VA, Biering-Sorensen S, Fisker AB, Bale C, Rasmussen SM, Christensen LD, et al. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau. J Infect Dis 2017; 215(8): 1188-96.

  91. Christensen K, Bjerregaard-Andersen M. Twin–singleton early-life survival in sub-Saharan Africa. The Lancet Global Health 2017; 5(7): e636-e7.

  92. Byberg S, Thysen SM, Rodrigues A, Martins C, Cabral C, Careme M, et al. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants. Vaccine 2017; 35(1): 33-9.

  93. Byberg S, Ostergaard MD, Rodrigues A, Martins C, Benn CS, Aaby P, et al. Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau. PLoS One 2017; 12(5): e0177984.

  94. Byberg S, Fisker AB, Thysen SM, Rodrigues A, Enemark U, Aaby P, et al. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau. Glob Health Action 2017; 10(1): 1329968.

  95. Byberg S, Fisker AB, Rodrigues A, Balde I, Enemark U, Aaby P, et al. Household experience and costs of seeking measles vaccination in rural Guinea-Bissau. Trop Med Int Health 2017; 22(1): 12-20.

  96. Byberg S, Benn CS. Placebo use in vaccine trials: Caution when using active vaccines as placebo. Vaccine 2017; 35(9): 1211.

  97. Birk NM, Nissen TN, Zingmark V, Kjaergaard J, Thostesen LM, Kofoed PE, et al. Bacillus Calmette-Guerin vaccination, thymic size, and thymic output in healthy newborns. Pediatr Res 2017; 81(6): 873-80.

  98. Birk NM, Nissen TN, Ladekarl M, Zingmark V, Kjaergaard J, Jensen TM, et al. The association between Bacillus Calmette-Guerin vaccination (1331 SSI) skin reaction and subsequent scar development in infants. BMC Infect Dis 2017; 17(1): 540.

  99. Birk NM, Nissen TN, Kjaergaard J, Hartling HJ, Thostesen LM, Kofoed PE, et al. Effects of Bacillus Calmette-Guerin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial. Sci Rep 2017; 7(1): 12398.

  100. Biering-Sorensen S, Aaby P, Lund N, Monteiro I, Jensen KJ, Eriksen HB, et al. Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; 65(7): 1183-90.

  101. Benn CS, Sørup S, Aaby P. The sequence of vaccinations to test the non-specific effects of vaccines. BMJ Rapid Responses 2017.

  102. Benn CS, Sørup S, Aaby P. Beneficial non-specific reduction in hospital admissions for respiratory infections following MMR and MenC vaccinations in the Netherlands. BMJ rapid responses 2017.

  103. Benn CS, Jacobsen LH, Fisker AB, Rodrigues A, Sartono E, Lund N, et al. Campaigns with oral polio vaccine may lower mortality and create unexpected results. Vaccine 2017; 35(8): 1113-6.

  104. Benn CS, Fisker AB, Aaby P. Serious danger signals: Response to: The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial. Int J Epidemiol 2017; 46(5): 1718-20.

  105. Benn CS. We Need Studies of the Mortality Effect of Vitamin A Supplementation, Not Surveys of Vitamin A Deficiency. Nutrients 2017; 9(3).

  106. Baek O, Jensen KJ, Andersen A, Bale C, Martins C, Biering-Sorensen S, et al. Seasonal and sex-specific variations in haematological parameters in 4 to 5.5-month-old infants in Guinea-Bissau, West Africa. Trans R Soc Trop Med Hyg 2017; 111(1): 30-7.

  107. Andersen A, Bjerregaard-Andersen M, Rodrigues A, Umbasse P, Fisker AB. Sex-differential effects of diphtheria-tetanus-pertussis vaccine for the outcome of paediatric admissions? A hospital based observational study from Guinea-Bissau. Vaccine 2017; 35(50): 7018-25.

  108. Aaby P, Ravn H, Fisker AB, Rodrigues A, Benn CS. Is diphtheria-tetanus-pertussis (DTP) associated with increased female mortality? A meta-analysis testing the hypotheses of sex-differential non-specific effects of DTP vaccine. Trans R Soc Trop Med Hyg 2016; 110(10): 570-81.

  109. Aaby P, Ravn H, Benn CS, Rodrigues A, Samb B, Ibrahim SA, et al. Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis. Pediatr Infect Dis J 2016; 35(11): 1232-41.

  110. Aaby P, Ravn H, Benn CS. The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis Vaccine. Pediatr Infect Dis J 2016; 35(11): 1247-57.

  111. Aaby P, Nielsen J, Benn CS, Trape JF. Sex-differential effects on mortality of BCG and diphtheria-tetanus-pertussis vaccines in a rural area with high vaccination coverage: observational study from Senegal. Trans R Soc Trop Med Hyg 2016; 110(9): 527-33.

  112. Aaby P, Andersen A, Martins CL, Fisker AB, Rodrigues A, Whittle HC, et al. Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine. BMJ open 2016; 6(12): e013335.

  113. Yoshida S, Martines J, Lawn JE, Wall S, Souza JP, Rudan I, et al. Setting research priorities to improve global newborn health and prevent stillbirths by 2025. J Glob Health 2016; 6(1): 010508.

  114. Yokoyama Y, Jelenkovic A, Sund R, Sung J, Hopper JL, Ooki S, et al. Twin's Birth-Order Differences in Height and Body Mass Index From Birth to Old Age: A Pooled Study of 26 Twin Cohorts Participating in the CODATwins Project. Twin Res Hum Genet 2016; 19(2): 112-24.

  115. Warsame M, Gyapong M, Mpeka B, Rodrigues A, Singlovic J, Babiker A, et al. Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 63(suppl 5): S312-S21.

  116. von Kalckreuth V, Konings F, Aaby P, Adu-Sarkodie Y, Ali M, Aseffa A, et al. The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S9-S16.

  117. Ursing J, Rombo L, Rodrigues A, Kofoed PE. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial. PLoS One 2016; 11(9): e0161495.

  118. Ursing J, Rombo L, Bergqvist Y, Rodrigues A, Kofoed PE. High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria. J Infect Dis 2016; 213(8): 1315-21.

  119. Thomsen D, Christiansen M, Medina C, Erikstrup C, Honge BL. Discovery of a novel HLA-B*15 allele, HLA-B*15:379, in a patient from Guinea-Bissau. HLA 2016; 88(4): 203-4.

  120. Tchounga BK, Honge BL, Eholie SP, Coffie PA, Jespersen S, Wejse C, et al. Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa. AIDS 2016; 30(17): 2707-14.

  121. Saadatian-Elahi M, Aaby P, Shann F, Netea MG, Levy O, Louis J, et al. Heterologous vaccine effects. Vaccine 2016; 34(34): 3923-30.

  122. Steiniche D, Jespersen S, Erikstrup C, Krarup H, Handberg A, Ostergaard L, et al. Diabetes mellitus and impaired fasting glucose in ART-naive patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional study. Trans R Soc Trop Med Hyg 2016; 110(4): 219-27.

  123. Sorup S, Stensballe LG, Krause TG, Aaby P, Benn CS, Ravn H. Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study. Open Forum Infect Dis 2016; 3(1): ofv204.

  124. Sorup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study. Vaccine 2016; 34(50): 6172-80.

  125. Sorensen A, Jespersen S, Katzenstein TL, Medina C, Te Dda S, Correira FG, et al. Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-Bissau. Infect Dis (Lond) 2016; 48(8): 604-11.

  126. Silventoinen K, Jelenkovic A, Sund R, Hur YM, Yokoyama Y, Honda C, et al. Genetic and environmental effects on body mass index from infancy to the onset of adulthood: an individual-based pooled analysis of 45 twin cohorts participating in the COllaborative project of Development of Anthropometrical measures in Twins (CODATwins) study. Am J Clin Nutr 2016; 104(2): 371-9.

  127. Rasmussen SM, Biering-Sorensen S, Byberg S, Andersen A, Bjerregaard-Andersen M, Rodrigues A, et al. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau. BMC Pediatr 2016; 16(1): 199.

  128. Rasmussen DN, Wejse C, Larsen O, Da Silva Z, Aaby P, Sodemann M. The when and how of male circumcision and the risk of HIV: a retrospective cross-sectional analysis of two HIV surveys from Guinea-Bissau. Pan Afr Med J 2016; 23: 21.

  129. Pisani E, Aaby P, Breugelmans JG, Carr D, Groves T, Helinski M, et al. Beyond open data: realising the health benefits of sharing data. BMJ 2016; 355: i5295.

  130. Park SE, Pak GD, Aaby P, Adu-Sarkodie Y, Ali M, Aseffa A, et al. The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S23-31.

  131. Panzner U, Pak GD, Aaby P, Adu-Sarkodie Y, Ali M, Aseffa A, et al. Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S56-68.

  132. Nissen TN, Birk NM, Kjaergaard J, Thostesen LM, Pihl GT, Hoffmann T, et al. Adverse reactions to the Bacillus Calmette-Guerin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Vaccine 2016; 34(22): 2477-82.

  133. Mutua MK, Kimani-Murage E, Ngomi N, Ravn H, Mwaniki P, Echoka E. Fully immunized child: coverage, timing and sequencing of routine immunization in an urban poor settlement in Nairobi, Kenya. Trop Med Health 2016; 44: 13.

  134. Mogensen SW, Aaby P, Smedman L, Martins CL, Rodrigues A, Benn CS, et al. Introduction of standard measles vaccination in an urban African community in 1979 and overall child survival: a reanalysis of data from a cohort study. BMJ open 2016; 6(12): e011317.

  135. Klein SL, Shann F, Moss WJ, Benn CS, Aaby P. RTS,S Malaria Vaccine and Increased Mortality in Girls. MBio 2016; 7(2): e00514-16.

  136. Kjaergaard J, Stensballe LG, Birk NM, Nissen TN, Thostesen LM, Pihl GT, et al. Bacillus Calmette-Guerin vaccination at birth: Effects on infant growth. A randomized clinical trial. Early Hum Dev 2016; 100: 49-54.

  137. Kjaergaard J, Stensballe LG, Birk NM, Nissen TN, Foss KT, Thostesen LM, et al. Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial. PLoS One 2016; 11(4): e0154541.

  138. Kjaergaard J, Birk NM, Nissen TN, Thostesen LM, Pihl GT, Benn CS, et al. Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial. Pediatr Res 2016; 80(5): 681-5.

  139. Kiraly N, Aage S, Benn CS. Disparity between vitamin A-induced Th1-dependent oral tolerance in newborn mice and vitamin A-induced atopic sensitization in Guinean girls. Mucosal Immunol 2016; 9(2): 564.

  140. Jespersen S, Honge BL, Esbjornsson J, Medina C, da Silva Te D, Correira FG, et al. Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off. Trop Med Int Health 2016; 21(2): 253-62.

  141. Jensen KJ, Fisker AB, Andersen A, Sartono E, Yazdanbakhsh M, Aaby P, et al. The effects of vitamin A supplementation with measles vaccine on leucocyte counts and in vitro cytokine production. Br J Nutr 2016; 115(4): 619-28.

  142. Jensen KJ, Benn CS, van Crevel R. Unravelling the nature of non-specific effects of vaccines-A challenge for innate immunologists. Semin Immunol 2016; 28(4): 377-83.

  143. Jensen AK, Ravn H, Sorup S, Andersen P. A marginal structural model for recurrent events in the presence of time-dependent confounding: non-specific effects of vaccines on child hospitalisations. Stat Med 2016; 35(27): 5051-69.

  144. Jelenkovic A, Sund R, Hur YM, Yokoyama Y, Hjelmborg JV, Moller S, et al. Genetic and environmental influences on height from infancy to early adulthood: An individual-based pooled analysis of 45 twin cohorts. Sci Rep 2016; 6: 28496.

  145. Im J, Nichols C, Bjerregaard-Andersen M, Sow AG, Lofberg S, Tall A, et al. Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S50-5.

  146. Honge BL, Jespersen S, Medina C, Wejse C, Erikstrup C. Comment on Lo et al.: Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients. J Med Virol 2016; 88(10): 1653-4.

  147. Honge BL, Jespersen S, Aunsborg J, Mendes DV, Medina C, da Silva Te D, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. Pan Afr Med J 2016; 25: 40.

  148. Honge BL, Andersen MN, Jespersen S, Medina C, Correira FG, Jakobsen MR, et al. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients. J Acquir Immune Defic Syndr 2016; 72(3): 254-8.

  149. Hennild DE, Bjerregaard-Andersen M, Joaquim LC, Christensen K, Sodemann M, Beck-Nielsen H, et al. Prevalence of impaired glucose tolerance and other types of dysglycaemia among young twins and singletons in Guinea-Bissau. BMC Endocr Disord 2016; 16(1): 46.

  150. Hasselbalch H, Jeppesen DL, Ersbøll AK, Lisse IM, Nielsen MB. Sonographic measurement of thymic size in healthy neonates. Acta Radiologica 2016; 38(1): 95-8.

  151. Group WGS. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med 2016; 14: 79.

  152. Frankel H, Byberg S, Bjerregaard-Andersen M, Martins CL, Aaby P, Benn CS, et al. Different effects of BCG strains - A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau. Vaccine 2016; 34(38): 4586-93.

  153. Fisker AB, Biering-Sorensen S, Lund N, Djana Q, Rodrigues A, Martins CL, et al. Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau. Vaccine 2016; 34(38): 4551-7.

  154. Fisker AB. The question should be whether the timing of vaccination optimises the impact on child health. BMJ 2016; 352: i1713.

  155. Dyrehave C, Rasmussen DN, Honge BL, Jespersen S, Correia FG, Medina C, et al. Nonadherence is Associated with Lack of HIV-Related Knowledge: A Cross-Sectional Study among HIV-Infected Individuals in Guinea-Bissau. J Int Assoc Provid AIDS Care 2016; 15(4): 350-8.

  156. Charles MK, Lindegren ML, Wester CW, Blevins M, Sterling TR, Dung NT, et al. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries. PLoS One 2016; 11(4): e0153243.

  157. Byberg S, Fisker AB. Is introduction of IPV “Good news for billions of children”? The Lancet Infectious Diseases 2016; 16(4): 409.

  158. Borggren M, Jensen SS, Heyndrickx L, Palm AA, Gerstoft J, Kronborg G, et al. Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark. AIDS Res Hum Retroviruses 2016; 32(5): 434-42.

  159. Benn CS, Sorup S. Commentary: BCG has no beneficial non-specific effects on Greenland. An answer to the wrong question? Int J Epidemiol 2016; 45(6): 2131-3.

  160. Benn CS, Fisker AB, Whittle HC, Aaby P. Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A Review. EBioMedicine 2016; 10: 312-7.

  161. Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, et al. Immunologic response in treatment-naive HIV-2-infected patients: the IeDEA West Africa cohort. J Int AIDS Soc 2016; 19(1): 20044.

  162. Andersen A, Rieckmann A. Using mi impute chained to fit ANCOVA models in randomized trials with censored dependent and independent variables. Stata Journal 2016; 16(3): 650-61.

  163. Al-Emran HM, Krumkamp R, Dekker DM, Eibach D, Aaby P, Adu-Sarkodie Y, et al. Validation and Identification of Invasive Salmonella Serotypes in Sub-Saharan Africa by Multiplex Polymerase Chain Reaction. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S80-2.

  164. Al-Emran HM, Eibach D, Krumkamp R, Ali M, Baker S, Biggs HM, et al. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016; 62 Suppl 1: S42-6.

  165. Aage S, Kiraly N, Da Costa K, Byberg S, Bjerregaard-Andersen M, Fisker AB, et al. Neonatal vitamin A supplementation associated with increased atopy in girls. Allergy 2015; 70(8): 985-94.

  166. Aaby P, Rodrigues A, Kofoed P-E, Benn CS. RTS,S/AS01 malaria vaccine and child mortality. The Lancet 2015; 386(10005): 1735-6.

  167. Aaby P, Nielsen J, Benn CS, Trape JF. Sex-differential and non-specific effects of routine vaccinations in a rural area with low vaccination coverage: an observational study from Senegal. Trans R Soc Trop Med Hyg 2015; 109(1): 77-84.

  168. Aaby P, Martins CL, Ravn H, Rodrigues A, Whittle HC, Benn CS. Is early measles vaccination better than later measles vaccination? Trans R Soc Trop Med Hyg 2015; 109(1): 16-28.

  169. Zumla A, Maeurer M, Marais B, Chakaya J, Wejse C, Lipman M, et al. Commemorating World Tuberculosis Day 2015. Int J Infect Dis 2015; 32: 1-4.

  170. WorldWide Antimalarial Resistance Network Lumefantrine PKPDSG. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Med 2015; 13: 227.

  171. Wejse C, Patsche CB, Kuhle A, Bamba FJ, Mendes MS, Lemvik G, et al. Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis. Int J Infect Dis 2015; 32: 128-34.

  172. Wejse C. Tuberculosis elimination in the post Millennium Development Goals era. Int J Infect Dis 2015; 32: 152-5.

  173. Timmermann CA, Biering-Sorensen S, Aaby P, Fisker AB, Monteiro I, Rodrigues A, et al. Tuberculin reaction and BCG scar: association with infant mortality. Trop Med Int Health 2015; 20(12): 1733-44.

  174. Thysen SM, Aaby P, Benn CS, Fisker AB. Changes in BCG Vaccination Policy Should Consider the Effect on Child Health. J Infect Dis 2015; 212(8): 1341-2.

  175. Thostesen LM, Nissen TN, Kjaergaard J, Pihl GT, Birk NM, Benn CS, et al. Bacillus Calmette-Guerin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial. Contemp Clin Trials 2015; 42: 213-8.

  176. Storgaard L, Rodrigues A, Martins C, Nielsen BU, Ravn H, Benn CS, et al. Development of BCG Scar and Subsequent Morbidity and Mortality in Rural Guinea-Bissau. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; 61(6): 950-9.

  177. Sorup S, Benn CS, Stensballe LG, Aaby P, Ravn H. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact. Vaccine 2015; 33(1): 237-45.

  178. Silventoinen K, Jelenkovic A, Sund R, Honda C, Aaltonen S, Yokoyama Y, et al. The CODATwins Project: The Cohort Description of Collaborative Project of Development of Anthropometrical Measures in Twins to Study Macro-Environmental Variation in Genetic and Environmental Effects on Anthropometric Traits. Twin Res Hum Genet 2015; 18(4): 348-60.

  179. Rudolf F, Wejse C. Tuberculosis case detection revisited: better testing might not improve outcomes. The Lancet Global Health 2015; 3(8): e424-e5.

  180. Rieckmann A, Benn CS. Making the most of measles vaccination, Archives of Disease in Childhood. eLetter BMJ 2015.

  181. Rieckmann A, Benn CS. Making the most of measles vaccination, Archives of Disease in Childhood. eLetter 2015.

  182. Rabna P, Ramos J, Ponce G, Sanca L, Mane M, Armada A, et al. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa. PLoS One 2015; 10(5): e0127536.

  183. Nichols C, Cruz Espinoza LM, von Kalckreuth V, Aaby P, Ahmed El Tayeb M, Ali M, et al. Bloodstream Infections and Frequency of Pretreatment Associated With Age and Hospitalization Status in Sub-Saharan Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; 61 Suppl 4: S372-9.

  184. Mutua MK, Ochako R, Ettarh R, Ravn H, Echoka E, Mwaniki P. Effects of low birth weight on time to BCG vaccination in an urban poor settlement in Nairobi, Kenya: an observational cohort study. BMC Pediatr 2015; 15: 45.

  185. Lund N, Andersen A, Hansen AS, Jepsen FS, Barbosa A, Biering-Sorensen S, et al. The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; 61(10): 1504-11.

  186. Kotze SR, Zinyama-Gutsire R, Kallestrup P, Benn CS, Gomo E, Gerstoft J, et al. HIV and schistosomiasis in rural Zimbabwe: the association of retinol-binding protein with disease progression, inflammation and mortality. Int J Infect Dis 2015; 33: 159-64.

  187. Kaestel P, Aaby P, Ritz C, Friis H. Markers of iron status are associated with stage of pregnancy and acute-phase response, but not with parity among pregnant women in Guinea-Bissau. Br J Nutr 2015; 114(7): 1072-9.

  188. Jovel IT, Kofoed PE, Rombo L, Rodrigues A, Ursing J. Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012. Antimicrob Agents Chemother 2015; 59(2): 872-9.

  189. Jesson J, Koumakpai S, Diagne NR, Amorissani-Folquet M, Koueta F, Aka A, et al. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort. Pediatr Infect Dis J 2015; 34(7): e159-68.

  190. Jespersen S, Tolstrup M, Honge BL, Medina C, Te Dda S, Ellermann-Eriksen S, et al. High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1/2 dual infections in Guinea-Bissau. Virol J 2015; 12: 41.

  191. Jespersen S, Honge BL, Oliveira I, Medina C, da Silva Te D, Correira FG, et al. Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. Int J Epidemiol 2015; 44(3): 756-63.

  192. Jespersen S, Honge BL, Medina C, da Silva Te D, Correira FG, Laursen AL, et al. Lack of awareness of treatment failure among HIV-1-infected patients in Guinea-Bissau - a retrospective cohort study. J Int AIDS Soc 2015; 18: 20243.

  193. Jespersen S. PI or NNRTI as first-line HIV treatment in a West African population with low adherence – the PIONA trial; 2015.

  194. Jensen KJ, Larsen N, Biering-Sorensen S, Andersen A, Eriksen HB, Monteiro I, et al. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial. J Infect Dis 2015; 211(6): 956-67.

  195. Jelenkovic A, Yokoyama Y, Sund R, Honda C, Bogl LH, Aaltonen S, et al. Zygosity Differences in Height and Body Mass Index of Twins From Infancy to Old Age: A Study of the CODATwins Project. Twin Res Hum Genet 2015; 18(5): 557-70.

  196. Honge BL, Jespersen S, Olesen JS, Erikstrup C, Wejse C. Rapid tests for HIV type discrimination in West Africa may perform differently. J Int AIDS Soc 2015; 18(1): 19460.

  197. Honge BL, Jespersen S, Bjarnason Obinah MP, Medina C, da Silva Te D, da Silva ZJ, et al. Interobserver variation of the rapid test SD bioline HIV-1/2 3.0 for HIV type discrimination: experiences from Guinea-Bissau. J Acquir Immune Defic Syndr 2015; 68(2): e23-5.

  198. Harouna AM, Amorissani-Folquet M, Eboua FT, Desmonde S, N'Gbeche S, Aka EA, et al. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Cote d'Ivoire: a prospective cohort study. BMC Infect Dis 2015; 15: 317.

  199. Haraldsdottir TL, Rudolf F, Bjerregaard-Andersen M, Joaquim LC, Stochholm K, Gomes VF, et al. Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital Bissau. Trans R Soc Trop Med Hyg 2015; 109(6): 400-7.

  200. Group WARNWADIS. The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient data. The Lancet Infectious Diseases 2015; 15(6): 692-702.

  201. Group WAbCTABS, Dahal P, d'Alessandro U, Dorsey G, Guerin PJ, Nsanzabana C, et al. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med 2015; 13: 212.

  202. Fryer HR, Van Tienen C, Van Der Loeff MS, Aaby P, Da Silva ZJ, Whittle H, et al. Predicting the extinction of HIV-2 in rural Guinea-Bissau. AIDS 2015; 29(18): 2479-86.

  203. Flanagan KL, Jensen KJ. Sex Differences in Outcomes of Infections and Vaccinations in Under Five Year Old Children. In: Roberts CW, Klein SL, eds. Sex and Gender Differences in Infection and Treatments for Infectious Diseases: Springer Verlag; 2015.

  204. Fisker AB, Rodrigues A, Martins C, Ravn H, Byberg S, Thysen S, et al. Reduced All-cause Child Mortality After General Measles Vaccination Campaign in Rural Guinea-Bissau. Pediatr Infect Dis J 2015; 34(12): 1369-76.

  205. Desmonde S, Eboua FT, Malateste K, Dicko F, Ekouevi DK, Ngbeche S, et al. Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation. AIDS 2015; 29(12): 1527-36.

  206. Clarke MS, Benn CS. Unusual positive effects from vaccines need to be reported - They represent a resource that could lead to new treatment strategies. Vaccine 2015; 33(28): 3162-3.

  207. Blok BA, Arts RJ, van Crevel R, Benn CS, Netea MG. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. J Leukoc Biol 2015; 98(3): 347-56.

  208. Biering-Sorensen S, Jensen KJ, Aamand SH, Blok B, Andersen A, Monteiro I, et al. Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial. Vaccine 2015; 33(17): 2056-65.

  209. Biering-Sorensen S, Andersen A, Ravn H, Monterio I, Aaby P, Benn CS. Early BCG vaccine to low-birth-weight infants and the effects on growth in the first year of life: a randomised controlled trial. BMC Pediatr 2015; 15: 137.

  210. Benn CS, Aaby P, Fisker AB. Neonatal vitamin A: time to move on? The Lancet 2015; 386(9989): 132-3.

  211. Benn CS, Aaby P, Fisker A. Vitamin A: The immunomodulator. World Nutrition 2015; 6(4): 318-21.

  212. Benn CS, Aaby P, Arts RJ, Jensen KJ, Netea MG, Fisker AB. An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality. Int J Epidemiol 2015; 44(3): 906-18.

  213. Benn CS, Fisker AB, Aaby P. Response to: J Mason et al. Vitamin A policies need rethinking. Int J Epidemiol 2015; 44(1): 366-7.

  214. Benn CS. Book Review: The Vitamin A Story: Lifting the Shadow of DeathThe Vitamin A Story: Lifting the Shadow of Death. By SembaR. D. Published by Karger, 2012. ISBN: 9783318021882. Perspectives in Public Health 2015; 135(5): 264-.

  215. Ballif M, Renner L, Claude Dusingize J, Leroy V, Ayaya S, Wools-Kaloustian K, et al. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc 2015; 4(1): 30-8.

  216. Arts RJ, Blok BA, Aaby P, Joosten LA, de Jong D, van der Meer JW, et al. Long-term in vitro and in vivo effects of gamma-irradiated BCG on innate and adaptive immunity. J Leukoc Biol 2015; 98(6): 995-1001.

  217. Arts RJ, Blok BA, van Crevel R, Joosten LA, Aaby P, Benn CS, et al. Vitamin A induces inhibitory histone methylation modifications and down-regulates trained immunity in human monocytes. J Leukoc Biol 2015; 98(1): 129-36.

  218. Abo Y, Zannou Djimon M, Messou E, Balestre E, Kouakou M, Akakpo J, et al. Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration. BMC Infect Dis 2015; 15: 176.

  219. Aaby P, Martins CL, Garly ML, Andersen A, Fisker AB, Claesson MH, et al. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014; 59(4): 484-92.

  220. Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 2014; 15(10): 895-9.

  221. Aaby P, Benn CS. Should we introduce a malaria vaccine which may increase child mortality? . Plos Med 2014.

  222. Yoshida S, Rudan I, Lawn JE, Wall S, Souza JP, Martines J, et al. Newborn health research priorities beyond 2015. The Lancet 2014; 384(9938): e27-e9.

  223. White MJ, Tacconelli A, Chen JS, Wejse C, Hill PC, Gomes VF, et al. Epiregulin (EREG) and human V-ATPase (TCIRG1): genetic variation, ethnicity and pulmonary tuberculosis susceptibility in Guinea-Bissau and The Gambia. Genes Immun 2014; 15(6): 370-7.

  224. Wejse C. Point-of-care diagnostics for tuberculosis elimination? The Lancet 2014; 383(9915): 388-90.

  225. Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, et al. Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study. BMJ open 2014; 4(6).

  226. Villumsen M. Possible Non-targeted Protection of Infections and Inflammatory Diseases by Smallpox Vaccination. Copenhagen: University of Copenhagen; 2014.

  227. Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg 2014; 91(4): 833-43.

  228. Ursing J, Rombo L, Rodrigues A, Aaby P, Kofoed PE. Malaria transmission in Bissau, Guinea-Bissau between 1995 and 2012: malaria resurgence did not negatively affect mortality. PLoS One 2014; 9(7): e101167.

  229. Ursing J, Eksborg S, Rombo L, Bergqvist Y, Blessborn D, Rodrigues A, et al. Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance. PLoS One 2014; 9(1): e86801.

  230. Thysen SM, Byberg S, Pedersen M, Rodrigues A, Ravn H, Martins C, et al. BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study. BMC Public Health 2014; 14: 1037.

  231. Sorup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA 2014; 311(8): 826-35.

  232. Sorup S. Non-specific beneficial effects of measles-mumps-rubella vaccination in Danish children. Copenhagen: University of Copenhagen; 2014.

  233. Sankoh O, Welaga P, Debpuur C, Zandoh C, Gyaase S, Poma MA, et al. The non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance Systems. Int J Epidemiol 2014; 43(3): 645-53.

  234. Sankoh O, Sharrow D, Herbst K, Whiteson Kabudula C, Alam N, Kant S, et al. The INDEPTH standard population for low- and middle-income countries, 2013. Glob Health Action 2014; 7: 23286.

  235. Rudolf F, Haraldsdottir TL, Mendes MS, Wagner AJ, Gomes VF, Aaby P, et al. Can tuberculosis case finding among health-care seeking adults be improved? Observations from Bissau. Int J Tuberc Lung Dis 2014; 18(3): 277-85.

  236. Rudolf F. The Bandim TBscore--reliability, further development, and evaluation of potential uses. Glob Health Action 2014; 7: 24303.

  237. Richard SA, Black RE, Gilman RH, Guerrant RL, Kang G, Lanata CF, et al. Catch-up growth occurs after diarrhea in early childhood. The Journal of nutrition 2014; 144(6): 965-71.

  238. Ndondoki C, Dicko F, Ahuatchi Coffie P, Kassi Eboua T, Ekouevi DK, Kouadio K, et al. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa. J Int AIDS Soc 2014; 17: 18737.

  239. Martins CL, Benn CS, Andersen A, Bale C, Schaltz-Buchholzer F, Do VA, et al. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. J Infect Dis 2014; 209(11): 1731-8.

  240. Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, et al. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age. J Infect Dis 2014; 210(5): 693-700.

  241. Mane M. Mortality of Women of Reproductive Age and Maternal Mortality. Trends, Determinants and Causes in a Community Cohort in Guinea Bissau from 1996-2007. Copenhagen: University of Copenhagen; 2014.

  242. Lund N, Biering-Sorensen S, Andersen A, Monteiro I, Camala L, Jorgensen MJ, et al. Neonatal vitamin A supplementation associated with a cluster of deaths and poor early growth in a randomised trial among low-birth-weight boys of vitamin A versus oral polio vaccine at birth. BMC Pediatr 2014; 14: 214.

  243. Lewden C, Drabo YJ, Zannou DM, Maiga MY, Minta DK, Sow PS, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc 2014; 17: 18797.

  244. Lemvik G, Rudolf F, Vieira F, Sodemann M, Ostergaard L, Rodrigues A, et al. Decline in overall, smear-negative and HIV-positive TB incidence while smear-positive incidence stays stable in Guinea-Bissau 2004-2011. Trop Med Int Health 2014; 19(11): 1367-76.

  245. Lemvik G. Active TB among adults and latent TB among exposed children in Guinea-Bissau - risk factors and adherence to preventive therapy. Aarhus: University of Aarhus; 2014.

  246. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014; 6(2): 152-8.

  247. Jespersen S, Honge BL, Oliveira I, Medina C, da Silva Te D, Correia FG, et al. Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborations. Bull World Health Organ 2014; 92(12): 909-14.

  248. Jensen KJ, Sondergaard M, Andersen A, Sartono E, Martins C, Garly ML, et al. A randomized trial of an early measles vaccine at 4(1/2) months of age in Guinea-Bissau: sex-differential immunological effects. PLoS One 2014; 9(5): e97536.

  249. Jensen KJ, Karkov HS, Lund N, Andersen A, Eriksen HB, Barbosa AG, et al. The immunological effects of oral polio vaccine provided with BCG vaccine at birth: a randomised trial. Vaccine 2014; 32(45): 5949-56.

  250. Jaquet A, Horo A, Ekouevi DK, Toure B, Coffie PA, Effi B, et al. Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Cote d'Ivoire, West Africa. PLoS One 2014; 9(3): e90625.

  251. Isendahl J, Manjuba C, Rodrigues A, Xu W, Henriques-Normark B, Giske CG, et al. Prevalence of community-acquired bacteraemia in Guinea-Bissau: an observational study. BMC Infect Dis 2014; 14: 3859.

  252. Honge BL, Jespersen S, Medina C, Te Dda S, da Silva ZJ, Lewin S, et al. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One 2014; 9(6): e99971.

  253. Honge BL, Jespersen S, Medina C, da Silva Te D, da Silva ZJ, Lewin SR, et al. Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study. Int J Infect Dis 2014; 28: 35-40.

  254. Honge BL, Bjarnason Obinah MP, Jespersen S, Medina C, Te Dda S, da Silva ZJ, et al. Performance of 3 rapid tests for discrimination between HIV-1 and HIV-2 in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 2014; 65(1): 87-90.

  255. Honge B, Jespersen S, Medina C, Te D, da Silva Z, Ostergaard L, et al. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Med 2014; 15(9): 571-6.

  256. Hansen AS, Lund N, Flanagan KL, Rodrigues A, Njie-Jobe J, Sanyang LC, et al. Randomized trial: The effect of oral polio vaccine at birth on polio antibody titers at 6weeks and 6months of age. Trials in Vaccinology 2014; 3: 33-9.

  257. Flanagan KL, Jensen KJ. Sex Differences in Outcomes of Infections and Vaccinations in Under Five Year Old Children. In: Roberts CW, Klein SL, eds. Sex and Gender Differences in Infection and Treatments for Infectious Diseases: Springer Verlag; 2014.

  258. Fisker AB, Ravn H, Rodrigues A, Ostergaard MD, Bale C, Benn CS, et al. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau. Vaccine 2014; 32(5): 598-605.

  259. Fisker AB, Hornshøj L, Rodrigues A, Balde I, Fernandes M, Benn CS, et al. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study. The Lancet Global Health 2014; 2(8): e478-e87.

  260. Fisker AB, Benn CS, Ravn H, Aaby P. Reply to Dr Schmid et al. Vaccine 2014; 32: 2668-9.

  261. Fisker AB, Bale C, Rodrigues A, Balde I, Fernandes M, Jorgensen MJ, et al. High-dose vitamin A with vaccination after 6 months of age: a randomized trial. Pediatrics 2014; 134(3): e739-48.

  262. Eriksen HB, Lund N, Biering-Sorensen S, Correia C, Barbosa A, Andersen A, et al. Does oral polio vaccine at birth affect the size of the thymus? Observations within a randomized trial. Vaccine 2014; 32(26): 3293-9.

  263. Eriksen HB, Biering-Sorensen S, Lund N, Correia C, Rodrigues A, Andersen A, et al. Factors associated with thymic size at birth among low and normal birth-weight infants. J Pediatr 2014; 165(4): 713-21.

  264. Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, et al. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc 2014; 17: 19045.

  265. Dicko F, Desmonde S, Koumakpai S, Dior-Mbodj H, Koueta F, Baeta N, et al. Reasons for hospitalization in HIV-infected children in West Africa. J Int AIDS Soc 2014; 17: 18818.

  266. Desmonde S, Dicko F, Koueta F, Eboua T, Balestre E, Amani-Bosse C, et al. Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children. AIDS 2014; 28(11): 1645-55.

  267. Depledge DP, Gray ER, Kundu S, Cooray S, Poulsen A, Aaby P, et al. Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau. J Virol 2014; 88(24): 13936-46.

  268. Christensen LD, Eriksen HB, Biering-Sorensen S, Bale C, Do VA, Andersen A, et al. The effect of early measles vaccination on thymic size. A randomized study from Guinea-Bissau. Vaccine 2014; 32(15): 1641-4.

  269. Bärnighausen T, Berkley S, Bhutta ZA, Bishai DM, Black MM, Bloom DE, et al. Reassessing the value of vaccines. The Lancet Global Health 2014; 2(5): e251-e2.

  270. Bjerregaard-Andersen M, Biering-Sorensen S, Gomes GM, Bidonga A, Jensen DM, Rodrigues A, et al. Infant twin mortality and hospitalisations after the perinatal period - a prospective cohort study from Guinea-Bissau. Trop Med Int Health 2014; 19(12): 1477-87.

  271. Benn CS, Martins CL, Fisker AB, Diness BR, Garly ML, Balde I, et al. Interaction between neonatal vitamin A supplementation and timing of measles vaccination: a retrospective analysis of three randomized trials from Guinea-Bissau. Vaccine 2014; 32(42): 5468-74.

  272. Benn CS, Diness BR, Balde I, Rodrigues A, Lausch KR, Martins CL, et al. Two different doses of supplemental vitamin A did not affect mortality of normal-birth-weight neonates in Guinea-Bissau in a randomized controlled trial. The Journal of nutrition 2014; 144(9): 1474-9.

  273. Ballif M, Nhandu V, Wood R, Dusingize JC, Carter EJ, Cortes CP, et al. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. Int J Tuberc Lung Dis 2014; 18(11): 1327-36.

  274. Andersen A, Jensen KJ, Erikstrup C, Ravn H, Fisker AB, Lisse IM, et al. Both very low- and very high in vitro cytokine responses were associated with infant death in low-birth-weight children from Guinea Bissau. PLoS One 2014; 9(4): e93562.

  275. Wejse C, Furtado A, Camara C, Luneborg-Nielsen M, Sodemann M, Gerstoft J, et al. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis. Int J Infect Dis 2013; 17(10): e907-12.

  276. Villumsen M, Jess T, Sorup S, Ravn H, Sturegard E, Benn CS, et al. Risk of inflammatory bowel disease following Bacille Calmette-Guerin and smallpox vaccination: a population-based Danish case-cohort study. Inflamm Bowel Dis 2013; 19(8): 1717-24.

  277. Rudolf F, Lemvik G, Abate E, Verkuilen J, Schon T, Gomes VF, et al. TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis. Scand J Infect Dis 2013; 45(11): 825-36.

  278. Rudolf F, Joaquim LC, Vieira C, Bjerregaard-Andersen M, Andersen A, Erlandsen M, et al. The Bandim tuberculosis score: reliability and comparison with the Karnofsky performance score. Scand J Infect Dis 2013; 45(4): 256-64.

  279. Rudolf F. The bandim TBsc ore – reliability, further development and evaluation of potential uses. Århus: University of Aarhus; 2013.

  280. Roman VR, Jensen KJ, Jensen SS, Leo-Hansen C, Jespersen S, da Silva Te D, et al. Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau. AIDS Res Hum Retroviruses 2013; 29(11): 1504-12.

  281. Renner LA, Dicko F, Koueta F, Malateste K, Gueye RD, Aka E, et al. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS. J Int AIDS Soc 2013; 16: 18024.

  282. Rasmussen DN, da Silva Te D, Rodkjaer L, Oliveira I, Medina C, Barfod T, et al. Barriers and facilitators to antiretroviral therapy adherence among patients with HIV in Bissau, Guinea-Bissau: A qualitative study. Afr J AIDS Res 2013; 12(1): 1-8.

  283. Ozkaya Sahin G, Holmgren B, Sheik-Khalil E, da Silva Z, Nielsen J, Nowroozalizadeh S, et al. Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent. J Virol 2013; 87(1): 273-81.

  284. Orntoft NW, Thorsen K, Benn CS, Lemvik G, Nanque JR, Aaby P, et al. Leukocyte transcript alterations in West-African girls following a booster vaccination with diphtheria-tetanus-pertussis vaccine. Scand J Clin Lab Invest 2013; 73(4): 349-54.

  285. Martins C, Garly ML, Bale C, Rodrigues A, Benn CS, Whittle H, et al. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines. Vaccine 2013; 31(48): 5766-71.

  286. Mane M, Fisker AB, Ravn H, Aaby P, Rodrigues A. Trends and determinants of mortality in women of reproductive age in rural Guinea-Bissau, West Africa--a cohort study. BMC Womens Health 2013; 13: 48.

  287. Lund N. Investigating the non-specific mortality and morbidity impact of oral polio vaccine at birth. Copenhagen: University of Copenhagen; 2013.

  288. Kiraly N, Benn CS, Biering-Sorensen S, Rodrigues A, Jensen KJ, Ravn H, et al. Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long-term follow-up of a randomized controlled trial. Allergy 2013; 68(9): 1168-76.

  289. Honge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ open 2013; 3(10): e003499.

  290. Harpsoe MC, Basit S, Bager P, Wohlfahrt J, Benn CS, Nohr EA, et al. Maternal obesity, gestational weight gain, and risk of asthma and atopic disease in offspring: a study within the Danish National Birth Cohort. J Allergy Clin Immunol 2013; 131(4): 1033-40.

  291. Gomes VF, Andersen A, Lemvik G, Wejse C, Oliveira I, Vieira FJ, et al. Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study. BMJ open 2013; 3(3).

  292. Flanagan KL, van Crevel R, Curtis N, Shann F, Levy O, Optimmunize N. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013; 57(2): 283-9.

  293. Fisker AB, Bale C, Jorgensen MJ, Balde I, Hornshoj L, Bibby BM, et al. High-dose vitamin A supplementation administered with vaccinations after 6 months of age: sex-differential adverse reactions and morbidity. Vaccine 2013; 31(31): 3191-8.

  294. Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, Cortes CP, et al. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PLoS One 2013; 8(10): e77697.

  295. Eriksen HB. Determinants of Thymic Size in Guinea-Bissau and the Impact of Routine Vaccinations. Copenhagen: University of Copenhagen; 2013.

  296. Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, et al. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One 2013; 8(6): e66135.

  297. Danneskiold-Samsoe N, Fisker AB, Jorgensen MJ, Ravn H, Andersen A, Balde ID, et al. Determinants of vitamin a deficiency in children between 6 months and 2 years of age in Guinea-Bissau. BMC Public Health 2013; 13: 172.

  298. Collins R, Hu T, Wejse C, Sirugo G, Williams S, Moore J. Multifactor dimensionality reduction reveals a three-locus epistatic interaction associated with susceptibility to pulmonary tuberculosis. BioData Mining 2013; 6(1): 4.

  299. Bjerregaard-Andersen M, Hansen L, da Silva LI, Joaquim LC, Hennild DE, Christiansen L, et al. Risk of metabolic syndrome and diabetes among young twins and singletons in Guinea-Bissau. Diabetes Care 2013; 36(11): 3549-56.

  300. Bjerregaard-Andersen M, Gomes MA, Joaquim LC, Rodrigues A, Jensen DM, Christensen K, et al. Establishing a twin registry in Guinea-Bissau. Twin Res Hum Genet 2013; 16(1): 179-84.

  301. Biering-Sorensen S, Fisker AB, Ravn H, Camala L, Monteiro I, Aaby P, et al. The effect of neonatal vitamin A supplementation on growth in the first year of life among low-birth-weight infants in Guinea-Bissau: two by two factorial randomised controlled trial. BMC Pediatr 2013; 13: 87.

  302. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013; 34(9): 431-9.

  303. Benn CS, Fisker AB, Aaby P. Vitamin A supplementation in Indian children. The Lancet 2013; 382(9892): 593.

  304. Andersen A, Roth A, Jensen KJ, Erikstrup C, Lisse IM, Whittle H, et al. The immunological effect of revaccination with Bacille Calmette-Guerin vaccine at 19 months of age. Vaccine 2013.

  305. Andersen A, Benn CS, Jorgensen MJ, Ravn H. Censored correlated cytokine concentrations: multivariate Tobit regression using clustered variance estimation. Stat Med 2013; 32(16): 2859-74.

  306. Aaby P, Whittle H, Stabell Benn C. Vaccine programmes must consider their effect on general resistance. BMJ 2012; 344: e3769.

  307. Aaby P, Roth A, Biering-Sorensen S, Ravn H, Rodrigues A, Whittle H, et al. No evidence of bias in trial showing BCG reduces neonatal mortality. J Infect Dis 2012; 205(3): 515-7.

  308. Aaby P, Ravn H, Roth A, Rodrigues A, Lisse IM, Diness BR, et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Archives of Disease in Childhood 2012; 97(8): 685-91.

  309. Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle H. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ open 2012; 2: e000761. doi:10.1136/bmjopen-2011-.

  310. Aaby P, Martins C, Benn CS, Whittle H. The new decade of vaccines. Lancet 2012; 379(9810): 25-6; author reply 7.

  311. Aaby P, Benn CS. Saving lives by training innate immunity with bacille Calmette-Guerin vaccine. Proceedings of the National Academy of Sciences of the United States of America 2012; 109(43): 17317-8.

  312. Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ open 2012; 2(3).

  313. Aaby P. Measles infection. In: K S-G, PR D, DW P, DS P, eds. Handbook of Clinical Gender Medicine. Basel: Karger; 2012: 405-13.

  314. Welaga P, Nielsen J, Adjuik M, Debpuur C, Ross DA, Ravn H, et al. Non-specific effects of diphtheria-tetanus-pertussis and measles vaccinations? An analysis of surveillance data from Navrongo, Ghana. Tropical Medicine & International Health 2012.

  315. Velez Edwards DR, Tacconelli A, Wejse C, Hill PC, Morris GA, Edwards TL, et al. MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms. PLoS One 2012; 7(2): e32275.

  316. van Tienen C, McConkey SJ, de Silva TI, Cotten M, Kaye S, Sarge-Njie R, et al. Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau. AIDS Res Hum Retroviruses 2012; 28(6): 584-90.

  317. van Tienen C, de Silva TI, Alcantara LC, Onyango CO, Jarju S, Goncalves N, et al. Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau. PLoS neglected tropical diseases 2012; 6(6): e1690.

  318. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H. Use of Antibiotics during Pregnancy Increases the Risk of Asthma in Early Childhood. J Pediatr 2012.

  319. Semba RD. The vitamin A story--lifting the shadow of death. Preface. World Rev Nutr Diet 2012; 104: VII-X.

  320. Rudolf F, Joaquim LC, Vieira C, Bjerregaard-Andersen M, Andersen A, Erlandsen M, et al. The Bandim tuberculosis score: Reliability and comparison with the Karnofsky performance score. Scand J Infect Dis 2012.

  321. Richard SA, Black RE, Gilman RH, Guerrant RL, Kang G, Lanata CF, et al. Wasting is associated with stunting in early childhood. The Journal of nutrition 2012; 142(7): 1291-6.

  322. Rasmussen J, Andersen A, Fisker AB, Ravn H, Sodemann M, Rodrigues A, et al. Mid-upper-arm-circumference and mid-upper-arm circumference z-score: the best predictor of mortality? Eur J Clin Nutr 2012; 66(9): 998-1003.

  323. Rabna P, Andersen A, Wejse C, Oliveira I, Gomes VF, Haaland MB, et al. Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment. PLoS One 2012; 7(8): e43933.

  324. Ozkaya Sahin G, Holmgren B, da Silva Z, Nielsen J, Nowroozalizadeh S, Esbjornsson J, et al. Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1. J Virol 2012; 86(2): 961-71.

  325. Oliveira I, Andersen A, Furtado A, Medina C, da Silva D, da Silva ZJ, et al. Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study. BMJ open 2012; 2(6).

  326. Lund N, Andersen A, Monteiro I, Aaby P, Benn CS. No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment. Vaccine 2012; 30(47): 6694-9.

  327. Lassen J, Jensen AK, Bager P, Pedersen CB, Panum I, Norgaard-Pedersen B, et al. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. Am J Epidemiol 2012; 176(9): 803-7.

  328. Kristensen K, Hjuler T, Ravn H, Simoes EA, Stensballe LG. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012; 54(6): 810-17.

  329. Karlsson I, Kloverpris H, Jensen KJ, Stryhn A, Buus S, Karlsson A, et al. Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccines. AIDS Res Hum Retroviruses 2012; 28(11): 1434-43.

  330. Kaestel P, Martinussen T, Aaby P, Michaelsen KF, Friis H. Serum retinol is associated with stage of pregnancy and the acute phase response in pregnant women in Guinea-Bissau. The Journal of nutrition 2012; 142(5): 942-7.

  331. Jorgensen MJ, Fisker AB, Sartono E, Andersen A, Erikstrup C, Lisse IM, et al. The effect of at-birth vitamin A supplementation on differential leucocyte counts and in vitro cytokine production: an immunological study nested within a randomised trial in Guinea-Bissau. Br J Nutr 2012: 1-11.

  332. Jorgensen MJ, Fisker AB, Erikstrup C, Claesson MH, Benn CS. SNP may modify the effect of vitamin A supplementation at birth on cytokine production in a whole blood culture assay. Br J Nutr 2012; 107(5): 615-20.

  333. Jensen KJ, Gomez Roman VR, Jensen SS, Leo-Hansen C, Karlsson I, Katzenstein TL, et al. Clade A HIV-1 Gag-Specific T Cell Responses Are Frequent but Do Not Correlate with Viral Loads in a Cohort of Treatment-Naive HIV-Infected Individuals Living in Guinea-Bissau. Clinical and vaccine immunology : CVI 2012; 19(12): 1999-2001.

  334. Hornshoj L, Benn CS, Fernandes M, Rodrigues A, Aaby P, Fisker AB. Vaccination coverage and out-of-sequence vaccinations in rural Guinea-Bissau: an observational cohort study. BMJ open 2012; 2(6): pii: e001509.

  335. Hirve S, Bavdekar A, Juvekar S, Benn CS, Nielsen J, Aaby P. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine 2012: Nov 26;30(50):7300-8. doi: 10.1016/j.vaccine.2012.09.035. Epub  Sep 26.

  336. Gomez Roman VR, Jensen SS, Leo-Hansen C, Jensen KJ, Janitzek CM, Rodrigues CM, et al. Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervals. Clinical and vaccine immunology : CVI 2012; 19(8): 1322-5.

  337. Fisker AB, Aaby P, Bale C, Balde I, Biering-Sorensen S, Agergaard J, et al. Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-Bissau. BMJ open 2012; 2(1): e000448.

  338. Fisker A, Aaby P, Benn C. Re: There is no need for further placebo-controlled trials. BMJ open 2012; 2.

  339. de Silva TI, Aasa-Chapman M, Cotten M, Hue S, Robinson J, Bibollet-Ruche F, et al. Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes. J Virol 2012; 86(2): 930-46.

  340. Bjerregaard-Andersen M, Lund N, Jepsen FS, Camala L, Gomes MA, Christensen K, et al. A prospective study of twinning and perinatal mortality in urban Guinea-Bissau. BMC pregnancy and childbirth 2012; 12: 140.

  341. Biering-Sorensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012; 31(3): 306-8.

  342. Biering-Sorensen S, Sondergaard G, Andersen KV, Andersen AM, Mortensen LH. Time trends in socio-economic factors and risk of hospitalisation with infectious diseases in pre-school children 1985-2004: a Danish register-based study. Paediatric and perinatal epidemiology 2012; 26(3): 226-35.

  343. Benn CS, Aaby P. Does IPTi decrease malaria morbidity but not mortality? Lancet 2012; 380(9846): 958-60.

  344. Benn CS, Aaby P. Diphtheria-tetanus-pertussis vaccination administered after measles vaccine: increased female mortality? Pediatr Infect Dis J 2012; 31(10): 1095-7.

  345. Benn CS. Combining Vitamin A and Vaccines: Convenience or Conflict? DMSc Thesis. Dan med J 2012; 59(1).

  346. Andersen A, Benn CS, Jorgensen MJ, Ravn H. Censored correlated cytokine concentrations: multivariate Tobit regression using clustered variance estimation. Statistics in medicine 2012: DOI: 10.1002/sim.5696.

  347. Andersen A. Statistical analysis of population-based immunological studies. Copenhagen: University of Copenhagen; 2012.

  348. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011; 204(2): 245-52.

  349. Aaby P, Benn CS. Non-specific and sex-differential effects of routine vaccines: What evidence is needed to take these effects into consideration in low-income countries? Human Vaccines 2011; 7(1).

  350. Yakymenko D, Benn CS, Martins C, Diness BR, Fisker AB, Rodrigues A, et al. The impact of different doses of vitamin A supplementation on male and female mortality. A randomised trial from Guinea-Bissau. BMC Pediatr 2011; 11: 77.

  351. Vinner L, Holmgren B, Jensen KJ, Esbjornsson J, Borggren M, Hentze JL, et al. Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries. APMIS 2011; 119(8): 487-97.

  352. Ursing J, Kofoed PE, Rodrigues A, Blessborn D, Thoft-Nielsen R, Bjorkman A, et al. Similar Efficacy and Tolerability of Double-Dose Chloroquine and Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in Guinea-Bissau: A Randomized Trial. Journal of Infectious Diseases 2011; 203(1): 109-16.

  353. Thomsen SF, Stensballe LG. Respiratory Syncytial Virus and Asthma in Twin Children: Lessons from the Population-Based Danish Registries. Current Respiratory Medicine Reviews 2011; 7(3): 167-71.

  354. Sorup S, Villumsen M, Ravn H, Benn CS, Sorensen TI, Aaby P, et al. Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. Int J Epidemiol 2011; 40(4): 955-63.

  355. Rasmussen TA, Søgaard OS, Camara C, Andersen PL, Wejse C. Serum procalcitonin in pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease 2011; 15(2): 251-6.

  356. Porskrog A, Bjerregaard-Andersen M, Oliveira I, Joaquim LC, Camara C, Andersen PL, et al. Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspects. International Journal of Tuberculosis and Lung Disease 2011; 15(4): 459-64.

  357. Nielsen J, Prudhon C, de Radigues X. Trends in malnutrition and mortality in Darfur, Sudan, between 2004 and 2008: a meta-analysis of publicly available surveys. Int J Epidemiol 2011; 40(4): 971-84.

  358. Nichols RA, Averbeck KT, Poulsen AG, al Bassam MM, Cabral F, Aaby P, et al. Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics 2011; 3(1): 12-8.

  359. Morris GA, Edwards DR, Hill PC, Wejse C, Bisseye C, Olesen R, et al. Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina. PLoS One 2011; 6(2): e16656.

  360. Martins C. Measles vaccination in Guinea-Bissau: Strategies to reduce disease burden and improve child survival. Copenhagen: University of Copenhagen; 2011.

  361. Kofoed PE, Ursing J, Rodrigues A, Rombo L. Paracetamol versus placebo in treatment of non-severe malaria in children in Guinea-Bissau: a randomized controlled trial. Malar J 2011; 10: 148.

  362. Kamper-Jorgensen M, Benn CS, Wohlfahrt J. Childcare and health: a review of using linked national registers. Scand J Public Health 2011; 39(7 Suppl): 126-30.

  363. Jørgen MJ. Understanding the immunological effects of vitamin A supplementation. Copenhagen: University of Copenhagen; 2011.

  364. Jorgensen MJ, Hein-Kristensen L, Hempel C, Ravn H, Wiese L, Kurtzhals JA, et al. The effect of vitamin A supplementation and diphtheria-tetanus-pertussis vaccination on parasitaemia in an experimental murine malaria model. Scand J Infect Dis 2011; 43(4): 296-303.

  365. Hennig BJ, Velez-Edwards DR, Schim van der Loeff MF, Bisseye C, Edwards TL, Tacconelli A, et al. CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa. Journal of Acquired Immune Deficiency Syndromes 2011; 56(1): 1-8.

  366. Gomes VF, Wejse C, Oliveira I, Andersen A, Vieira FJ, Carlos LJ, et al. Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau. The International Journal of Tuberculosis and Lung Disease 2011; 15(12): 1637-43.

  367. Gomes VF, Andersen A, Wejse C, Oliveira I, Vieira FJ, Joaquim LC, et al. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau. Thorax 2011; 66(2): 163-7.

  368. Flanagan KL, Klein SL, Skakkebaek NE, Marriott I, Marchant A, Selin L, et al. Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine 2011; 29(13): 2349-54.

  369. Fisker AB, Aaby P, Rodrigues A, Frydenberg M, Bibby BM, Benn CS. Vitamin A supplementation at birth might prime the response to subsequent vitamin A supplements in girls. Three year follow-up of a randomized trial. PLoS One 2011; 6(8): e23265.

  370. Fisker AB. Evaluation of the WHO vitamin A supplementation policy in Guinea-Bissau. Aarhus: University of Aarhus; 2011.

  371. Diness BR, Martins CL, Bale C, Garly ML, Ravn H, Rodrigues A, et al. The effect of high-dose vitamin A supplementation at birth on measles incidence during the first 12 months of life in boys and girls: an unplanned study within a randomised trial. British Journal of Nutrition 2011: 1-4.

  372. Biai S, Rodrigues A, Nielsen J, Sodemann M, Aaby P. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. Vaccine 2011; 29(20): 3662-9.

  373. Biai S. Evaluations of interventions to reduce hospital and and community mortality. Copenhagen: University of Copenhagen; 2011.

  374. Benn CS, Fisker AB, Aaby P. With heterogeneous and potentially harmful effects in existing trials it would be unethical not to conduct further studies of the effect of vitamin A supplementation. Rapid responses. BMJ 2011.

  375. Benn CS, Fisker AB, Aaby P. Heterogeneous effects on child survival in neonatal vitamin A supplementation trials. Lancet 2011; 377: 1314-5.

  376. Benn CS. Combining vitamin A and vaccines. Convenience or conflict? Copenhagen: University of Copenhagen; 2011.

  377. Bale C, Garly ML, Martins C, Nielsen J, Whittle H, Aaby P. Risk factors for measles in young infants in an urban African area with high measles vaccination coverage. Pediatr Infect Dis J 2011; 30(8): 689-93.

  378. Agergaard J, Nante E, Poulstrup G, Nielsen J, Flanagan KL, Ostergaard L, et al. Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. Vaccine 2011; 29(3): 487-500.

  379. Aaby P, Roth A, Benn C, Ravn H, A R, Lisse IM, et al. DSMB and patient safety. BMJ; rapid responses 2010.

  380. Aaby P, Martins CL, Garly ML, Bale C, Andersen A, Rodrigues A, et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010; 341: c6495.

  381. Whittle HC, Aaby P. Measles. Oxford Textbook of Medicine 2010; 7.5.6.

  382. van Tienen C, van der Loeff MF, Peterson I, Cotten M, Holmgren B, Andersson S, et al. HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007. Retrovirology 2010; 7: 50.

  383. van der Loeff MF, Larke N, Kaye S, Berry N, Ariyoshi K, Alabi A, et al. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 2010; 7: 46.

  384. Stensballe LG, Fullarton JR, Carbonell-Estrany X, Simoes EA. Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age. Pediatr Infect Dis J 2010; 29(4): 374-6.

  385. Shann F, Nohynek H, Scott JA, Hesseling A, Flanagan KL. Randomized Trials to Study the Nonspecific Effects of Vaccines in Children in Low-Income Countries. Pediatric Infectious Disease Journal 2010; 29(5): 457-61.

  386. Sartono E, Lisse IM, Terveer EM, van de Sande PJ, Whittle H, Fisker AB, et al. Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. PLoSOne 2010; 5(5): e10328.

  387. Sachdev HS, Kirkwood BR, Benn CS. Neonatal vitamin A supplementation and infant mortality. Bulletin of the World Health Organization 2010; 88: 875A-B.

  388. Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M, et al. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010; 340: c671.

  389. Rabna P, Andersen A, Wejse C, Oliveira I, Francisco Gomes V, Bonde Haaland M, et al. Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study. Inflammation 2010; 33(6): 374-80.

  390. Poulsen A, Roth A. 'Guinea-Bissau' in Mosby's 'Cultural Health Assessment'. In: D'Avanzo C, ed. 4th ed. Mosby: In Press; 2010.

  391. Poorisrisak P, Halkjaer LB, Thomsen SF, Stensballe LG, Kyvik KO, Skytthe A, et al. Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins. Chest 2010; 138(2): 338-44.

  392. Oliveira Souto IM. Implementation of HIV Programme in Guinea-Bissau. Setting up the West African Retrovirus and Acquired Immune Deficiency Cohort study. Copenhagen: University of Copemhagen; 2010.

  393. Oliveira I, Jensen-Fangel S, da Silva D, Ndumba A, Medina C, Nanadje A, et al. Epidemic Stevens–Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy? AIDS 2010; 24: 783-7.

  394. Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010; 201(8): 1150-4.

  395. Nielsen J, Sodemann M, Jakobsen M, Gustafson P, Benn CS, Aaby P. Sundhedsmæssige konsekvenser af en væbnet konflikt i Guinea-Bissau. Ugeskrift for Læger 2010; 172(2): 132-6.

  396. Kamper-Jørgensen M, Benn CS, Simonsen J, Thrane N, Wohlfahrt J. Clustering of acute respiratory infection hospitalizations in childcare facilities. Acta Paediatr 2010; 99(6): 877-82.

  397. Hein-Kristensen L, Jørgensen MJ, Ravn H, Wiese L, Kurtzhals J, Benn CS. Simultaneous Administration of Vitamin A and DTP Vaccine Modulates the Immune Response in a Murine Cerebral Malaria Model. Scandinavian Journal of Immunology 2010; 72(4): 302-8.

  398. Gomes V. Children exposed to tuberculosis at home: impact on mortality and the effect of using chemoprophylaxis in Guinea-Bissau, West Africa. Copenhagen: University of Copenhagen; 2010.

  399. Fisker AB. Comment on: ‘Maternal postpartum vitamin A supplementation for the prevention of mortality and morbidity in infancy: a systematic review of randomised controlled trials’. International Journal of Epidemiology 2010; 1-2.

  400. Fischer TK, Aaby P, Molbak K, Rodrigues A. Rotavirus disease in Guinea-Bissau, West Africa: a review of longitudinal community and hospital studies. Journal of Infectious Diseases 2010; 202 Suppl: S239-42.

  401. Diness BR, Christoffersen D, Pedersen UB, Rodrigues A, Fischer TK, Andersen A, et al. The Effect of High-Dose Vitamin A Supplementation Given with Bacille Calmette-Guerin Vaccine at Birth on Infant Rotavirus Infection and Diarrhea: A Randomized Prospective Study from Guinea-Bissau. Journal of Infectious Diseases 2010; 202: S243-S51.

  402. Bjerregaard-Andersen M, da Silva ZJ, Ravn P, Ruhwald M, Andersen PL, Sodemann M, et al. Tuberculosis burden in an urban population: a cross sectional tuberculosis survey from Guinea Bissau. BMC Infectious Diseases 2010; 10: 96.

  403. Benn CS, Fisker AB, Napirna BM, Roth A, Diness BR, Lausch KR, et al. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 2010; 340: c1101.

  404. Benn CS. We need to understand more about the factors which modify the effect of vitamin A. Sight and Life Magazine 2010; 1: 28-9.

  405. Andersen GS, Friis H, Michaelsen KF, Rodrigues A, Benn CS, Aaby P, et al. Effects of maternal micronutrient supplementation on fetal loss and under-2-years child mortality: long-term follow-up of a randomised controlled trial from Guinea-Bissau. African Journal of Reproductive Health 2010; 14(2): 17-26.

  406. Agergaard J, Lemvik G, Nante E, Helleberg M, Nielsen J, Benn CS, et al. Serological evidence for Chlamydia pneumoniae infection following diphtheria-tetanus-pertussis booster vaccination. Journal of Infectious Diseases and Immunity 2010; 2(1): 1-14.

  407. Aaby P, Ravn H, Benn CS. Poor control vaccines in two randomised trials of malaria vaccine? Vaccine 2009; 27(22): 2914-5.

  408. Aaby P, Martins C, Bale C, Garly M-L, Rodrigues A, Biai S, et al. Sex Differences in the Effect of Vaccines on the Risk of Hospitalization Due to Measles in Guinea-Bissau. Pediatric Infectious Disease Journal 2009: 1.

  409. Aaby P, Benn CS, Nielsen J, Ravn H. Sex-differential non-specific effects of BCG and DTP in Cebu, The Philippines. Int J Epidemiol 2009; 38(1): 320-3; author reply 3-4.

  410. Aaby P, Benn CS. Assessment of childhood immunisation coverage. The Lancet 2009; 373(9673): 1428.

  411. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, et al. Vitamin D as Supplementary Treatment for Tuberculosis: A Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine 2009; 179(9): 843-50.

  412. Wejse C, Gomes VF, Gustafson P, Aaby P, Lisse I, Andersen PL, et al. Improved vitamin D status despite allocation to placebo in a tuberculosis treatment trial: contamination bias? Author reply. Am J Respir Crit Care Med 2009; 180(2): 189-90.

  413. Weise C, Glerup H. Effect of Vitamin D on Tuberculosis and HIV Replication Depends on Conversion to Calcitriol and Concentration, author reply. American Journal of Respiratory and Critical Care Medicine 2009; 180: 795-6.

  414. Villumsen M, Sørup S, Jess T, Ravn H, Relander T, Baker JL, et al. Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: A Danish case-cohort study. Vaccine 2009; 27(49): 6950-8.

  415. Velez DR, Wejse C, Stryjewski ME, Abbate E, Hulme WF, Myers JL, et al. Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Human Genetics 2009; 127(1): 65-73.

  416. van Tienen C, van der Loeff MF, Zaman SMA, Vincent T, Sarge-Njie R, Peterson I, et al. Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau. Journal of Acquired Immune Deficiency Syndromes 2009; 53: 640-7.

  417. Ursing J, Kofoed P-E, Rodrigues A, Rombo L. No Seasonal Accumulation of Resistant P. falciparum when High-Dose Chloroquine Is Used. Plos One 2009; 4(8).

  418. Ursing J, Kofoed PE, Rodrigues A, Bergqvist Y, Rombo L. Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau. Antimicrob Agents Chemother 2009; 53(1): 180-5.

  419. Ursing J. Plasmodium falciparum response to chloroquine and artemisinin based combination therapy (ACT) in Guinea-Bissau. Stockholm: Karolinska Institutet, Stockholm University; 2009.

  420. Thomsen SF, van der Sluis S, Stensballe LG, Posthuma D, Skytthe A, Kyvik KO, et al. Exploring the Association between Severe Respiratory Syncytial Virus Infection and Asthma: A Registry-based Twin Study. American Journal of Respiratory and Critical Care Medicine 2009; 179(12): 1091-7.

  421. Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EAF. Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus. The Journal of Pediatrics 2009; 154(2): 296-8.e1.

  422. Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, et al. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. Journal of Allergy and Clinical Immunology 2009; 123(2): 398-403.

  423. Stensballe L, Brunbjergsimonsen J, Thomsen S, Hellesoelarsen A, Hovmandlysdal S, Aaby P, et al. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. Journal of Allergy and Clinical Immunology 2009; 123(1): 131-7.e1.

  424. Steenhard NR, Ørnbjerg N, Mølbak K. Concurrent infections and socioeconomic determinants of geohelminth infection: a community study of schoolchildren in periurban Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009; 103(8): 839-45.

  425. Raaby L, Bendix-Struve M, Nielsen J, Wejse C. Inter-observer variation of the Bandim TB-score. Scandinavian Journal of Infectious Diseases 2009; 41(3): 220-3.

  426. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Research Notes 2009; 2(1): 19.

  427. Rabna P, Andersen A, Wejse C, Oliveira I, Gomes VF, Haaland MB, et al. High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test. Tropical Medicine & International Health 2009; 14(9): 986-94.

  428. Rabna P. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Marker of Tuberculosis Treatment efficacy and Potential Prognostic marker for Survival in individuals with a TB negative diagnosis. A prospective, Longitudinal Cohort Study in Suspected Pulmonary Tuberculosis patients in Guinea-Bissau. Copenhagen: University of Copenhagen; 2009.

  429. Nowroozalizadeh S, Månsson F, da Silva Z, Repits J, Dabo B, Pereira C, et al. Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cytokine 2009; 46(3): 325-31.

  430. Martins C, Bale C, Garly M-L, Rodrigues A, Lisse IM, Andersen A, et al. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination. Vaccine 2009; 27(38): 5220-5.

  431. Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, et al. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Archives of Disease in Childhood 2009; 94(10): 785-9.

  432. Jallow S, Vincent T, Leligdowicz A, De Silva T, Van Tienen C, Alabi A, et al. Presence of a Multidrug‐Resistance Mutation in an HIV‐2 Variant Infecting a Treatment‐Naive Individual in Caio, Guinea Bissau. Clinical Infectious Diseases 2009; 48(12): 1790-3.

  433. Fine PEM, Williams TN, Aaby P, Källander K, Moulton LH, Flanagan KL, et al. Epidemiological studies of the ‘non-specific effects’ of vaccines: I - data collection in observational studies. Tropical Medicine & International Health 2009; 14(9): 969-76.

  434. Farrington CP, Firth MJ, Moulton LH, Ravn H, Andersen PK, Evans S. Epidemiological studies of the non-specific effects of vaccines: II - methodological issues in the design and analysis of cohort studies. Tropical Medicine & International Health 2009; 14(9): 977-85.

  435. Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, et al. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 2009; 11(3): 204-12.

  436. da Silva Z, NIelsen J, Andersen A, Oliveira I, Dias F, Rodrigues A, et al. Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections. AIDS 2009; 23: 637-43.

  437. da Silva Z. Trends in retroviral infection in Guinea-Bissau. Cross-sectional and longitudinal community studies. Copenhagen: University of Copenhagen; 2009.

  438. Benn CS, Aaby P, Nielsen J, Binka FN, Ross DA. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial. Am J Clin Nutr 2009; 90(3): 629-39.

  439. Benn CS, Martins C, Rodrigues A, Ravn H, Fisker AB, Christoffersen D, et al. The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-Bissau. International Journal of Epidemiology 2009; 38(1): 304-11.

  440. Benn CS, Martins C, Rodrigues A, Ravn H, Fisker AB, Christoffersen D, et al. The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-Bissau. Int J Epidemiol 2009; 38(1): 304-11.

  441. Benn CS, Lund S, Fisker A, Jorgensen MJ, Aaby P. Should infant girls receive micronutrient supplements? International Journal of Epidemiology 2009; 38(2): 586-90.

  442. Agergaard J. Randomised study of not providing diphtheria-tetanus-pertussis vaccine together with or after measles vaccination: Impact on morbidity and growth. Aarhus: Aarhus University; 2009.

  443. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, et al. TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2008; 40(2): 111-20.

  444. Wejse C. Tuberculosis and vitamin D - what is the evidence for interaction? Review. European Infectious Disease 2008; 2(1): 107-9.

  445. Ursing J, Rombo L, Kofoed P-E, Gil JP. Carriers, channels and chloroquine efficacy in Guinea-Bissau. Trends in Parasitology 2008; 24(2): 49-51.

  446. Thomsen SF, Stensballe LG, Skytthe A, Kyvik KO, Backer V, Bisgaard H. Increased Concordance of Severe Respiratory Syncytial Virus Infection in Identical Twins. Pediatrics 2008; 121(3): 493-6.

  447. Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, Aaby P, et al. Hospitalization for Respiratory Syncytial Virus Infection and Invasive Pneumococcal Disease in Danish Children Aged <2 Years: A Population‐Based Cohort Study. Clinical Infectious Diseases 2008; 46(8): 1165-71.

  448. Sodemann M, Nielsen J, Veirum J, Jakobsen MS, Biai S, Aaby P. Hypothermia of newborns is associated with excess mortality in the first 2 months of life in Guinea-Bissau, West Africa. Tropical Medicine & International Health 2008; 13(8): 980-6.

  449. Sodemann M, Benn CS, Aaby P. Improving child survival. Bandim Health Project 2003-2008 2008.

  450. Schmidt WP, Van Der Loeff MS, Aaby P, Whittle H, Bakker R, Buckner M, et al. Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau. Epidemiol Infect 2008; 136(4): 551-61.

  451. Rodrigues A, Schellenberg JA, Kofoed P-E, Aaby P, Greenwood B. Changing pattern of malaria in Bissau, Guinea Bissau. Tropical Medicine & International Health 2008; 13(3): 410-7.

  452. Norrgren HR, Bamba S, Larsen O, Da Silva Z, Aaby P, Koivula T, et al. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. Journal of Acquired Immune Deficiency Syndromes 2008; 48(5): 607-10.

  453. Martins CL, Garly ML, Bale C, Rodrigues A, Ravn H, Whittle HC, et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 2008; 337(jul24 2): a661-a.

  454. Hersoug L-G, Benn CS, Simonsen JB, Kamper-Jørgensen M, Linneberg A. Maternal employment in child-care institutions and the risk of infant wheeze and atopic dermatitis in the offspring. Pediatric Allergy and Immunology 2008; 19(8): 688-95.

  455. Garly M, Trautner S, Marx C, Danebod K, Nielsen J, Ravn H, et al. Thymus Size at 6 Months of Age and Subsequent Child Mortality. The Journal of Pediatrics 2008; 153(5): 683-8.e3.

  456. da Silva ZJ, Oliveira I, Andersen A, Dias F, Rodrigues A, Holmgren B, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS 2008; 22(10): 1195-202.

  457. Checkley W, Buckley G, Gilman RH, Assis AM, Guerrant RL, Morris SS, et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. International Journal of Epidemiology 2008.

  458. Benn CS, Whittle H, Fisker AB, Aaby P. Neonatal vitamin A supplementation in South Asia: Rapid implementation or understanding the variation? BMJ 2008.

  459. Benn CS, Friis H, Wejse C. Should Micronutrient Supplementation Be Integrated into the Case Management of Tuberculosis? The Journal of Infectious Diseases 2008; 197(11): 1487-9.

  460. Benn CS, Fisker AB, Rodrigues A, Ravn H, Sartono E, Whittle H, et al. Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment. PLoS One 2008; 3(12): e4056.

  461. Benn CS, Fisker AB, Jorgensen MJ, Aaby P. Conflicting evidence for neonatal vitamin A supplementation. Vaccine 2008; 26(33): 4111-2.

  462. Benn CS, Diness BR, Roth A, Nante E, Fisker AB, Lisse IM, et al. Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008; 336(7658): 1416-20.

  463. Benn CS, Diness BR, Roth A, Nante E, Fisker AB, Lisse IM, et al. Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008; 336(7658): 1416-20.

  464. Aaby P, Jensen H. Response to Deborah Lehmann. TMIH 2007; 12: 1270-1.

  465. Aaby P, Garly ML, Nielsen J, Ravn H, Martins C, Bale C, et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatric Infectious Disease Journal 2007; 26(3): 247-52.

  466. Aaby P, Biai S, Veirum JE, Sodemann M, Lisse I, Garly ML, et al. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau. Vaccine 2007; 25(7): 1265-9.

  467. Aaby P, Benn CS, Nielsen J, Lisse IM, Rodrigues A, Jensen H. DTP vaccination and child survival in observational studies with incomplete vaccination data. Tropical Medicine & International Health 2007; 12(1): 15-24.

  468. Aaby P. International health at home: learning from low-income countrie - secondary publication. Danish Medical Bulletin 2007; 54(2): 147-9.

  469. Aaby P. Is susceptibility to severe infection in low-income countries inherited or acquired? Journal of Internal Medicine 2007; 261(2).

  470. Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007; 86(5): 1376-83.

  471. Wejse C. The role of vitamin D in the pathogenesis and treatment of tuberculosis. Århus: University of Århus; 2007.

  472. Veirum JE, Sodeman M, Biai S, Hedegård K, Aaby P. Increased mortality in the year following discharge from a paediatric ward in Bissau, Guinea-Bissau. Acta Paediatr 2007; 96(12): 1832-8.

  473. Veirum JE, Biai S, Jakobsen M, Sandström A, Hedegaard K, Kofoed PE, et al. Persisting high hospital and community childhood mortality in an urban setting in Guinea-Bissau. Acta Paediatr 2007; 96(10): 1526-30.

  474. Valentiner-Branth P, Perch M, Nielsen J, Steinsland H, Garly ML, Fischer TK, et al. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations. Vaccine 2007; 25(14): 2733-41.

  475. Ursing J, Schmidt BA, Lebbad M, Kofoed PE, Dias F, Gil JP, et al. Chloroquine resistant P-falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: An effect of high chloroquine dosage? Infect Genet Evol 2007; 7(5): 555-61.

  476. Ursing J, Rodrigues A, Kofoed PE. Response to Laufer. NEJM 2007; 356: 868.

  477. Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. American Journal of Tropical Medicine and Hygiene 2007; 76(5): 844-8.

  478. Sodemann M. Too many chefs in Africa – secondary publication. Danish Medical Bulletin 2007; 54(1): 52-4.

  479. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7☆☆☆. Microbes and Infection 2007; 9(7): 806-12.

  480. Roth AE, Nielsen J. A non-beneficial effect of BCG on non-tuberculous childhood mortality? Vaccine 2007; 25(1): 12-3.

  481. Rodrigues Al, de Carvalho M, Monteiro S, Mikkelsen CS, Aaby P, M??lbak Kr, et al. Hospital Surveillance of Rotavirus Infection and Nosocomial Transmission of Rotavirus Disease Among Children in Guinea-Bissau. Pediatric Infectious Disease Journal 2007; 26(3): 233-7.

  482. Rodrigues A, Schellenberg JA, Roth A, Benn CS, Aaby P, Greenwood B. Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children. Tropical Medicine & International Health 2007; 12(2): 224-9.

  483. Orozova-Bekkevold I, Jensen H, Stensballe L, Olsen J. Maternal vaccination and preterm birth: using data mining as a screening tool. Pharmacy World & Science 2007; 29(3): 205-12.

  484. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P, et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes and Immunity 2007; 8(6): 456-67.

  485. Nielsen NM, Rostgaard K, Hjalgrim H, Askgaard D, Skinhoj P, Aaby P. Psychiatric hospitalizations in a cohort of Danish polio patients. Am J Epidemiol 2007; 165(3): 319-24.

  486. Nante JE, Diness BR, Ravn H, Roth A, Aaby P, Benn CS. No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau. Eur J Clin Nutr 2007; 62(7): 842-8.

  487. Masmas TN, Jensen H, Silva D, Høj L, Sandström A, Aaby P. Survival among motherless children in rural and urban areas in Guinea-Bissau. Acta Paediatr 2007; 93(1): 99-105.

  488. Leligdowicz A, Yindom LM, Onyango C, Sarge-Njie R, Alabi A, Cotten M, et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007; 117(10): 3067-74.

  489. Larsen JM, Benn CS, Fillie Y, van der Kleij D, Aaby P, Yazdanbakhsh M. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 2007; 121(2): 276-82.

  490. Kofoed PE, Ursing J, Rodrigues A, Rombo L. Failures following initial treatment for uncomplicated malaria: Quinine as second line therapy. Journal of Pediatric Infectious Diseases 2007; 2(3): 121-6.

  491. Kofoed PE, Ursing J, Poulsen A, Rodrigues A, Bergquist Y, Aaby P, et al. Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations. Trans R Soc Trop Med Hyg 2007; 101(3): 231-8.

  492. Kofoed P-E. Severe malaria in African children: Still a challenge. Journal of Pediatric Infectious Diseases 2007; 2(4): 181-2.

  493. Kitchen M, Quigley MA, Mwinga AM, Fuchs D, Lisse IM, Porter JDH, et al. HIV Progression and Predictors of Mortality in a Community-Based Cohort of Zambian Adults. Journal of the International Association of Physicians in AIDS Care (JIAPAC) 2007; 7(1): 17-26.

  494. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007; 39(4): 523-8.

  495. Kamper-Jørgensen M, Woodward A, Wohlfahrt J, Benn CS, Simonsen J, Hjalgrim H, et al. Childcare in the first 2 years of life reduces the risk of childhood acute lymphoblastic leukemia. Leukemia 2007; 22(1): 189-93.

  496. Kamper-Jørgensen M, Wohlfahrt J, Simonsen J, Benn CS. The Childcare Database: a valuable register linkage. Scandinavian Journal of Public Health 2007; 35(3): 323-9.

  497. Jensen H, Benn CS, Lisse IM, Rodrigues A, Andersen PK, Aaby P. Survival bias in observational studies of the impact of routine immunizations on childhood survival. Trop Med Int Health 2007; 12(1): 5-14.

  498. Jakobsen MS, Sodemann M, Mølbak K, Alvarenga I, Aaby P. Promoting breastfeeding through health education at the time of immunizations: a randomized trial from Guinea Bissau. Acta Paediatr 2007; 88(7): 741-7.

  499. Holmgren B, da Silva Z, Vastrup P, Larsen O, Andersson S, Ravn H, et al. Mortality associated with HIV-1, HIV-2, and HTLV-1 single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007; 4: -.

  500. Gustafson P, Lisse I, Gomes V, Vieira CS, Lienhardt C, Nauclér A, et al. Risk Factors for Positive Tuberculin Skin Test in Guinea-Bissau. Epidemiology 2007; 18(3): 340-7.

  501. Gustafson P, Gomes VF, Vieira CS, Samb B, Nauclér A, Aaby P, et al. Clinical Predictors for Death in HIV-positive and HIV-negative Tuberculosis Patients in Guinea-Bissau. Infection 2007; 35(2): 69-80.

  502. Garly ML, Nielsen J, Aaby P. The measure of effect is not transferable. BMJ; rapod responses 2007.

  503. Garly ML, Balé C, Martins CL, Whittle HC, Nielsen J, Lisse IM, et al. Measles in developing countries: Vitamin A and prophylactic antibiotics. BMJ; rapid responses 2007.

  504. Garly ML. The choice of antibiotic for prophylaxis. BMJ; rapid responses 2007.

  505. Fisker AB, Lisse IM, Aaby P, Erhardt JG, Rodrigues A, Bibby BM, et al. Effect of vitamin A supplementation with BCG vaccine at birth on vitamin A status at 6 wk and 4 mo of age. Am J Clin Nutr 2007; 86(4): 1032-9.

  506. Eriksson M, Sartono E, Martins CL, Balé C, Garly ML, Whittle H, et al. A comparison of ex vivo cytokine production in venous and capillary blood. Clinical & Experimental Immunology 2007; 150(3): 469-76.

  507. Diness BR, Fisker AB, Roth A, Yazdanbakhsh M, Sartono E, Whittle H, et al. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. Am J Clin Nutr 2007; 86(4): 1152-9.

  508. Diness BR. High-dose vitamin A supplementation with Bacille Calmette-Guérin vaccine at births. Copenhagen: University of Copenhagen; 2007.

  509. Biai S, Rodrigues A, Gomes M, Ribeiro I, Sodemann M, Alves F, et al. Reduced in-hospital mortality after improved management of children under 5 years admitted to hospital with malaria: randomised trial. BMJ 2007; 335(7625): 862-.

  510. Benn CS, Aaby P. Sex-differential responses to preventive health interventions. Maybe we treat boys and girls differently when we treat them equally? Secondary publication. Danish Medical Bulletin 2007; 54(2): 153-4.

  511. Benn CS, Fisker AB, Jorgensen MJ, Aaby P. Why worry: vitamin A with DTP vaccine? Vaccine 2007; 25(5): 777-9.

  512. Aaby P, Vessari H, Nielsen J, Maleta K, Benn CS, Jensen H, et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatric Infectious Disease Journal 2006; 25(8): 721-7.

  513. Aaby P, Jensen H, Walraven G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 2006; 24(22): 4701-8.

  514. Aaby P, Ibrahim SA, Libman MD, Jensen H. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa. Vaccine 2006; 24(15): 2764-71.

  515. Aaby P, Gustafson P, Roth A, Rodrigues A, Fernandes M, Sodemann M, et al. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine 2006; 24(29-30): 5718-25.

  516. Aaby P. International sundhed derhjemme: at tage erfaringerne med hjem. Ugeskrift for Læger 2006; 168(36): 3015-7.

  517. Ursing J, Kofoed P-E, Rombo L, Gil JP. No pfmdr1 Amplifications in Samples from Guinea-Bissau and Liberia Collected between 1981 and 2004. Journal of Infectious Diseases 2006; 194(5): 716-8.

  518. Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, Gustafson P, et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. ProcNatlAcadSciUSA 2006; 103(27): 10364-8.

  519. Stensballe LG, Kristensen K, Simoes EA, Jensen H, Nielsen J, Benn CS, et al. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics 2006; 118(5): e1360-8.

  520. Sodemann M, Biai S, Jakobsen MS, Aaby P. Knowing a medical doctor is associated with reduced mortality among sick children consulting a paediatric ward in Guinea-Bissau, West Africa. Tropical Medicine & International Health 2006; 11(12): 1868-77.

  521. Sodemann M. Der er for mange kokke i Afrika. Ugeskrift for Læger 2006; 168(36): 2999-3001.

  522. Sodeman M. Der er for mange kokke i Afrika. Ugeskr Laeger 2006; 186: 2999-3001.

  523. Roth A, Stensballe L, Garly M, Aaby P. Beneficial non-targeted effects of BCG—Ethical implications for the coming introduction of new TB vaccines. Tuberculosis 2006; 86(6): 397-403.

  524. Roth A, Sodemann M, Jensen H, Poulsen A, Gustafson P, Weise C, et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 2006; 17(5): 562-8.

  525. Roth A, Garly ML, Jensen H, Nielsen J, Aaby P. Bacillus Calmette-Guerin vaccination and infant mortality. Expert Rev Vaccines 2006; 5(2): 277-93.

  526. Rodrigues A, Fischer TK, Valentiner-Branth P, Nielsen J, Steinsland H, Perch M, et al. Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates? Vaccine 2006; 24(22): 4737-46.

  527. Qureshi K, Molbak K, Sandstrom A, Kofoed PE, Rodrigues A, Dias F, et al. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatric Infectious Disease Journal 2006; 25(12): 1163-6.

  528. Poulsen A, Stensballe LG, Nielsen J, Benn CS, Balde A, Roth A, et al. Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-bissau. Pediatric Infectious Disease Journal 2006; 25(11): 1025-31.

  529. Nielsen BB, Høj L, Hvidman LE, NIelsen J, Cardoso P, Aaby P. Reduceret post partum-blødning efter sublingval misoprostol: et randomiseret dobbeltblindt klinisk studie i et udviklingsland - sekundærpublikation Ugeskrift for Læger 2006; 168(13): 1341-3.

  530. Masmas TN, Garly M-L, Lisse IM, Rodriques A, Petersen PT, Birgens H. Inherited Hemoglobin Disorders in Guinea-Bissau, West Africa: A Population Study. Hemoglobin 2006; 30(3): 355-64.

  531. Linneberg A, Simonsen J, Petersen J, Stensballe L, Benn C. Differential effects of risk factors on infant wheeze and atopic dermatitis emphasize a different etiology. Journal of Allergy and Clinical Immunology 2006; 117(1): 184-9.

  532. Kofoed P-E, Rodrigues A, Aaby P, Rombo L. Continued efficacy of sulfadoxine–pyrimethamine as second line treatment for malaria in children in Guinea-Bissau. Acta Tropica 2006; 100(3): 213-7.

  533. Kofoed PE. Treatment of ucomplicated malaria in Guinea-Bissau. Stockholm: Karolinska Institutet; 2006.

  534. Kamper-Jorgensen M, Wohlfahrt J, Simonsen J, Gronbaek M, Benn CS. Population-Based Study of the Impact of Childcare Attendance on Hospitalizations for Acute Respiratory Infections. Pediatrics 2006; 118(4): 1439-46.

  535. Kamper-Jorgensen M. Temporal trend in paediatric infections in Denmark. Archives of Disease in Childhood 2006; 91(5): 401-4.

  536. Jensen ML, Dave S, Schim van der Loeff M, da Costa C, Vincent T, Leligdowicz A, et al. Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau. PLoS One 2006; 1: e101.

  537. Garly ML, Bale C, Martins CL, Whittle HC, Nielsen J, Lisse IM, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ 2006; 333(7581): 1245.

  538. Fisker AB. Let us protect the children not the policies.  Unplanned observations are essential for improving current policies. Global Forum for Health Research: Young voices in Research for Health 2006: 35-8.

  539. Benn CS, Aaby P. Kønsforskelle i respons på præventive sundhedsprogrammer. Måske behandler vi piger og drenge forskelligt, når vi behandler dem ens? Ugeskrift for Læger 2006; 168(36): 3045-6.

  540. Benn CS, Fisker AB, Diness BR, Aaby P. Neonatal vitamin a supplementation: sex-differential effects on mortality? Journal of Infectious Diseases 2006; 194(5): 719.

  541. Benn CS, Diness BR, Fisker AB, Christensen D, Friis H. Højdosis A-vitamin- tilskud sænker børnedødelighed i lavindkomstlande – kan det blive bedre? Ugeskrift for Læger 2006; 168(25): 2442-5.

  542. Aaby P, Rodrigues A, Biai S, Martins C, Veirum JE, Benn CS, et al. Vaccines and unexpected observations: flaws or cause for concern? Vaccine 2005; 23(19): 2407-8.

  543. Aaby P, Jensen H, Benn CS, Lisse IM. Non-specific effects of vaccination: survival bias may explain findings. BMJ 2005; 330(7495): 844-5; author reply 5.

  544. Aaby P, Jensen H. Do measles vaccines have non-specific effects on mortality? Bulletin of the World Health Organization 2005; 83(3): 238.

  545. Aaby P, Jensen H. Commentary: Contrary findings from Guinea-Bissau and Papua New Guinea. Int J Epidemiol 2005; 34(1): 149-51.

  546. Aaby P, Hedegaard K, Sodemann M, Nhante E, Veirum JE, Jakobsen M, et al. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau. Vaccine 2005; 23(14): 1746-51.

  547. Aaby P. Sundhedsforskning i et af verdens fattigste lande. Novo Nordisk Fondens Årskrift 2005; 2005: 34-7.

  548. Westergaard T, Rostgaard K, Wohlfahrt J, Andersen PK, Aaby P, Melbye M. Sibship characteristics and risk of allergic rhinitis and asthma. American Journal of Epidemiology 2005; 162(2): 125-32.

  549. Westergaard T. Westergaard et al. Respond to "Sibship Effects and a Call for a Comparative Disease Approach". American Journal of Epidemiology 2005; 162(2): 139-.

  550. Veirum JE, Sodemann M, Biai S, Jakobsen M, Garly ML, Hedegaard K, et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005; 23(9): 1197-204.

  551. Stensballe LG, Nante E, Jensen IP, Kofoed PE, Poulsen A, Jensen H, et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls - Community based case-control study. Vaccine 2005; 23(10): 1251-7.

  552. Stensballe LG, Kristensen K, Nielsen J, Aaby P. Diagnosis coding in The Danish National Patient Registry for respiratory syncytial virus infections. Scandinavian Journal of Infectious Diseases 2005; 37(10): 747-52.

  553. Stensballe LG. Risk factors for severe respiratory syncytial virus infection. Epidemiologic studies in a low- and a high-income setting. Copenhagen: University of Copenhagen; 2005.

  554. Steenhard NR. Concurrent infection with intestinal worms and bacteria in man and domestic animals. Copenhagen: University of Copenhagen; 2005.

  555. Sodemann M, Rodriques A, Nielsen J, Aaby P. Maternal Vulnerability and Socio-economic Inequalities in Child Mortality in West Africa: An Exploratory Study. 2005.

  556. Roth A, Sodemann M, Jensen H, Poulsen A, Gustafson P, Gomes J, et al. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine 2005; 23(30): 3991-8.

  557. Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. International Journal of Epidemiology 2005; 34(3): 540-7.

  558. Poulsen A, Cabral F, Nielsen J, Roth A, Lisse IM, Vestergaard BF, et al. Varicella zoster in Guinea-Bissau: intensity of exposure and severity of infection. Pediatric Infectious Disease Journal 2005; 24(2): 102-7.

  559. Poulsen A, Cabral F, Nielsen J, Roth A, Lisse I, Aaby P. Growth, morbidity and mortality after chickenpox infection in young children in Guinea-Bissau. J Infect 2005; 51(4): 307-13.

  560. Poulsen A. Determinants of severity of acute viral disease and their long-term consequences. Copenhagen: University of Copenhagen; 2005.

  561. Olesen AB, Andersen G, Jeppesen D, Benn CS, Juul S, Thestrup-Pedersen K. Thymus is Enlarged in Children with Current Atopic Dermatitis. A Cross-sectional Study. Acta Dermato-Venereologica 2005; -1(1): 1-.

  562. Nielsen NM, Eugen-Olsen J, Aaby P, Molbak K, Rodrigues A, Fischer TK. Characterisation of rotavirus strains among hospitalised and non-hospitalised children in Guinea-Bissau, 2002 A high frequency of mixed infections with serotype G8. J Clin Virol 2005; 34(1): 13-21.

  563. Nielsen J, Jensen H, Andersen PK. Creating a reference to a complex emergency situation using time series methods: War in Guinea-Bissau 1998-1999. J Appl Stat 2005; 32(1): 75-86.

  564. Nielsen J, Benn CS, Bale C, Martins C, Aaby P. Vitamin A supplementation during war-emergency in Guinea-Bissau 1998-1999. Acta Tropica 2005; 93(3): 275-82.

  565. Nielsen J. Mortality patterns and interventions during the war in Guinea-Bissau 1998-99. Statistical methods and inference in complex emergency situations. Copenhagen: University of Copenhagen; 2005.

  566. Lisse IM, Qureshi K, Poulsen A, Kofoed PE, Nielsen J, Vestergaard BF, et al. T-lymphocyte subsets and eosinophil counts in acute and convalescence chickenpox infection: a household study in Guinea-Bissau. J Infect 2005; 50(2): 125-9.

  567. Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. International Journal of Epidemiology 2005; 34(4): 914-23.

  568. Leutscher PDC, Pedersen M, Raharisolo C, Jensen JS, Hoffmann S, Lisse I, et al. Increased Prevalence of Leukocytes and Elevated Cytokine Levels in Semen from Schistosoma haematobium—Infected Individuals. Journal of Infectious Diseases 2005; 191(10): 1639-47.

  569. Knudsen TB, Gustafson P, Kronborg G, Kristiansen TB, Moestrup SK, Nielsen JO, et al. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. ClinMicrobiolInfect 2005; 11(9): 730-5.

  570. Kaestel P, Michaelsen KF, Aaby P, Friis H. Effects of prenatal multimicronutrient supplements on birth weight and perinatal mortality: a randomised, controlled trial in Guinea-Bissau. Eur J Clin Nutr 2005; 59(9): 1081-9.

  571. Kabir Z, Aaby P. Non-specific effect of measles vaccination on all-cause child mortality: revisited. Indian Pediatr 2005; 42(6): 541-4.

  572. Jensen H, Benn CS, Aaby P. DTP in low income countries: improved child survival or survival bias? BMJ 2005; 330(7495): 845-6.

  573. Jaffar S, Van der Loeff MS, Eugen-Olsen J, Vincent T, Sarje-Njie R, Ngom P, et al. Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau. AIDS Res Hum Retroviruses 2005; 21(6): 560-4.

  574. J N. Mortality patterns and interventions during the war in Guinea-Bissau 1998-99. Statistical methods and inference in complex emergency situations. Copenhagen: University of Copenhagen; 2005.

  575. Høj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005; 331(7519): 723.

  576. Broutin H, Mantilla-Beniers NB, Simondon F, Aaby P, Grenfell BT, Guegan JF, et al. Epidemiological impact of vaccination on the dynamics of two childhood diseases in rural Senegal. Microbes Infect 2005; 7(4): 593-9.

  577. Benn CS, Michaelsen KF. Does the effect of breast-feeding on atopic dermatitis depend on family history of allergy? The Journal of Pediatrics 2005; 147(1): 128-9.

  578. Benn CS, Melbye M, Wohlfahrt J, Björkstén B, Aaby P. Kohortestudie af effekten af søskende og infektionssygdomme på udvikling af atopisk dermatitis – sekundærpublikation. Ugeskrift for Læger 2005; 167(16): 1754-7.

  579. Benn CS, Martins C, Rodrigues A, Jensen H, Lisse IM, Aaby P. Randomised study of effect of different doses of vitamin A on childhood morbidity and mortality. BMJ 2005; 331(7530): 1428-32.

  580. Andersson S, Larsen O, Da Silva Z, Linder H, Norrgren H, Dias F, et al. Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau. Clin Exp Immunol 2005; 139(3): 483-9.

  581. Aaby P, Rodrigues A, Biai S, Martins C, Veirum JE, Benn CS, et al. Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004; 22(23-24): 3014-7.

  582. Aaby P, Jensen H, Rodrigues A, Garly ML, Benn CS, Lisse IM, et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. International Journal of Epidemiology 2004; 33(2): 367-73.

  583. Aaby P, Jensen H, Gomes J, Fernandes M, Lisse IM. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. International Journal of Epidemiology 2004; 33(2): 374-80.

  584. Aaby P, Benn CS, Lisse IM, Jensen H. Replicating findings from Guinea-Bissau? . BMJ Rapid responses 2004.

  585. Aaby P. Being wrong in the right direction? Lancet 2004; 364(9438): 984.

  586. Aaby P. Vet vi vad vi gör med vacciner? Läkartidningen 2004; 101(4): 2-5.

  587. Stensballe L, Poulsen A, Nante E, Jensen IP, Kofoed PE, Jensen H, et al. Mothers may transmit RSV infection more easily or severely to sons than daughters: community study from Guinea-Bissau. Scandinavian Journal of Infectious Diseases 2004; 36(4): 291-5.

  588. Steinsland H, Valentiner-Branth P, Aaby P, Molbak K, Sommerfelt H. Clonal relatedness of enterotoxigenic Escherichia coli strains isolated from a cohort of young children in Guinea-Bissau. J Clin Microbiol 2004; 42(7): 3100-7.

  589. Steinsland H, Valentiner-Branth P, Gjessing HK, Aaby P, Sommerfelt H, Molbak K. [Protection against enterotoxigenic Escherichia coli infections]. Ugeskrift for Læger 2004; 166(45): 4051-3.

  590. Sodemann M, Veirum J, Biai S, Nielsen J, Bale C, Skytte Jakobsen M, et al. Reduced case fatality among hospitalized children during a war in Guinea-Bissau: a lesson in equity. Acta Paediatr 2004; 93(7): 959-64.

  591. Simondon KB, Elguero E, Marra A, Diallo A, Aaby P, Simondon F. Season of birth is not associated with risk of early adult death in rural Senegal. International Journal of Epidemiology 2004; 33(1): 130-6.

  592. Roth A, Jensen H, Garly M-L, Djana Q, Martins CL, Sodemann M, et al. Low Birth Weight Infants and Calmette-Guerin Bacillus Vaccination at Birth: Community Study from Guinea-Bissau. Pediatric Infectious Disease Journal 2004; 23(6): 544-50.

  593. Poulsen A, Kæstel P, Kofoed PE. Rabies. A case of supposed exposure. Ugeskr Læger 2004; 166: 2676-7.

  594. Perch M, Kofoed P, Fischer TK, Co F, Rombo L, Aaby P, et al. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 2004; 26(5): 207-11.

  595. Nielsen NM, Rostgaard K, Askgaard D, Skinhoj P, Aaby P. Life-long morbidity among Danes with poliomyelitis. Archives of Physical Medicine and Rehabilitation 2004; 85(3): 385-91.

  596. Nielsen J, Valentiner-Branth P, Martins C, Cabral F, Aaby P. Malnourished children and supplementary feeding during the war emergency in Guinea-Bissau in 1998-1999. Am J Clin Nutr 2004; 80(4): 1036-42.

  597. Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes and Immunity 2004; 5(2): 122-9.

  598. Masmas TN, Jensen H, da Silva D, Hoj L, Sandstrom A, Aaby P. The social situation of motherless children in rural and urban areas of Guinea-Bissau. Soc Sci Med 2004; 59(6): 1231-9.

  599. Lizeng Q, Nilsson C, Sourial S, Andersson S, Larsen O, Aaby P, et al. Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals. Journal of Virology 2004; 78(13): 7016-22.

  600. Linneberg A, Petersen J, Gronbaek M, Benn CS. Alcohol during pregnancy and atopic dermatitis in the offspring. Clinical <html_ent glyph="@amp;" ascii="&amp;"/> Experimental Allergy 2004; 34(11): 1678-83.

  601. Kræstel P. Micronutrient supplementation and other predictors of birth size and perinatal mortality in Guinea-Bissau. Denmark; 2004.

  602. Kofoed P-E, Alfrangis M, Poulsen A, Rodrigues A, Gjedde SB, Rønn A, et al. Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau. Tropical Medicine & International Health 2004; 9(1): 171-7.

  603. Kofoed PE, Rodrigues A, Co F, Hedegaard K, Rombo L, Aaby P. Which children come to the health centre for treatment of malaria? Acta Trop 2004; 90(1): 17-22.

  604. Jeppesen DL, Hasselbalch H, Lisse IM, Ersbøll AK, Engelmann MDM. T-lymphocyte subsets, thymic size and breastfeeding in infancy. Pediatric Allergy and Immunology 2004; 15(2): 127-32.

  605. Jensen H, Brookmeyer R, Aaby P, Andersen PK. Shared Frailty Model for Left-Truncated Multivariate Survival Data. Copenhagen: University of Copenhagen, 2004.

  606. Gustafson P, Gomes VF, Vieira CS, Rabna P, Seng R, Johansson P, et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol 2004; 33(1): 163-72.

  607. Garly ML, Jensen H, Martins CL, Bale C, Balde MA, Lisse IM, et al. Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study. Pediatric Infectious Disease Journal 2004; 23(12): 1086-92.

  608. Fine PE. Non-specific "non-effects" of vaccination. BMJ 2004; 329(7478): 1297-8.

  609. Dræbel TA. Public health response in a complex political emergency and its aftermath: the role of national health professionals in conflict and health system change in Guinea-Bissau. Copenhagen: University of Copenhagen; 2004.

  610. Bornman L, Campbell SJ, Fielding K, Bah B, Sillah J, Gustafson P, et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. Journal of Infectious Diseases 2004; 190(9): 1631-41.

  611. Benn CS, Wohlfahrt J, Aaby P, Westergaard T, Benfeldt E, Michaelsen KF, et al. Breastfeeding and risk of atopic dermatitis, by parental history of allergy, during the first 18 months of life. American Journal of Epidemiology 2004; 160(3): 217-23.

  612. Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004; 328(7450): 1223.

  613. Benn CS, Böttcher MF, Pedersen BV, Filteau SM, Duchén K. Mammary epithelial paracellular permeability in atopic and non-atopic mothers versus childhood atopy. Pediatric Allergy and Immunology 2004; 15(2): 123-6.

  614. Adam R. Specific and non-specific effects of BCG. Copenhagen: University of Copenhagen; 2004.

  615. Flanding M. Experiences of war Institute of Anthropology. Copenhagen: University of Copenhagen; 2003

     

  616. Aaby P, Jensen H, Whittle H. High-titre measles vaccine and female mortality. Lancet 2003; 362(9397): 1765.

  617. Aaby P, Jensen H, Simondon F, Whittle H. High-titer measles vaccination before 9 months of age and increased female mortality: do we have an explanation? Semin Pediatr Infect Dis 2003; 14(3): 220-32.

  618. Aaby P, Jensen H, Samb B, Cisse B, Sodemann M, Jakobsen M, et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003; 361(9376): 2183-8.

  619. Aaby P, Garly ML, Bale C, Martins C, Jensen H, Lisse I, et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Pediatric Infectious Disease Journal 2003; 22(9): 798-805.

  620. Aaby P, Bhuiya A, Nahar L, Knudsen K, de Francisco A, Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. International Journal of Epidemiology 2003; 32(1): 106-16.

  621. Whittle H, Aaby P. Measles. In: DJ W, JGG L, DA W, eds. Oxford Textbook of Medicine, 4th edition. Oxford: Oxford University Press; 2003.

  622. Westergaard T, Begtrup K, Rostgaard K, Krause TG, Benn CS, Melbye M. Reproductive history and allergic rhinitis among 31145 Danish women. Clinical Experimental Allergy 2003; 33(3): 301-5.

  623. Veirum JE. The impact of monitoring case management on mortality during and after hospitalization among children admitted to the pediatric ward, Hospital Simao Mendes, Guinea-Bissau. Copenhagen: University of Copenhagen; 2003.

  624. van der Loeff MS. HIV-2 in West Africa. Epidemiological studies. Amsterdam: University of Amsterdam; 2003.

  625. Valentiner-Branth P, Steinsland H, Fischer TK, Perch M, Scheutz F, Dias F, et al. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol 2003; 41(9): 4238-45.

  626. Stensballe LG, Devasundaram JK, Simoes EAF. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatric Infectious Disease Journal 2003; 22(2): S21-S32.

  627. Steinsland H, Valentiner-Branth P, Gjessing HK, Aaby P, Molbak K, Sommerfelt H. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet 2003; 362(9380): 286-91.

  628. Steinsland H. The epidemiology of enterotoxigenic Escherichia coli infection and diarrhea in early childhood. Bergen: University of Bergen; 2003.

  629. Steinsland H. Development and evaluation of genotypic assays for the detection and characterization of enterotoxigenic Escherichia coli. Diagnostic Microbiology and Infectious Disease 2003; 45(2): 97-105.

  630. Sodemann M, Aaby P. Bandim Health Project 1978-2003: Improving child health? . Århus: Bandim Health Project; 2003.

  631. Ronsmans C, Etard JF, Walraven G, Hoj L, Dumont A, Bernis L, et al. Maternal mortality and access to obstetric services in West Africa. Tropical Medicine and International Health 2003; 8(10): 940-8.

  632. Nielsen NM, Rostgaard K, Juel K, Askgaard D, Aaby P. Long-term mortality after poliomyelitis. Epidemiology 2003; 14(3): 355-60.

  633. Lagarde E, Schim van der Loeff M, Enel C, Holmgren B, Dray-Spira R, Pison G, et al. Mobility and the spread of human immunodeficiency virus into rural areas of West Africa. International Journal of Epidemiology 2003; 32(5): 744-52.

  634. Kofoed PE, Poulsen A, Co F, Hedegaard K, Aaby P, Rombo L. No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003; 97(4): 429-33.

  635. Kofoed PE, Lopez F, Aaby P, Hedegaard K, Rombo L. Can mothers be trusted to give malaria treatment to their children at home? Acta Trop 2003; 86(1): 67-70.

  636. Jakobsen MS, Sodemann M, Molbak K, Alvarenga IJ, Nielsen J, Aaby P. Termination of breastfeeding after 12 months of age due to a new pregnancy and other causes is associated with increased mortality in Guinea-Bissau. International Journal of Epidemiology 2003; 32(1): 92-6.

  637. Jakobsen M, Sodemann M, Nylen G, Bale C, Nielsen J, Lisse I, et al. Breastfeeding status as a predictor of mortality among refugee children in an emergency situation in Guinea-Bissau. Tropical Medicine & International Health 2003; 8(11): 992-6.

  638. Høj L, da Silva D, Hedegaard K, Sandström A, Aaby P. Maternal mortality: only 42 days? BJOG: an International Journal of Obstetrics and Gynaecology 2003; 110(11): 995-1000.

  639. Holmgren B, da Silva Z, Larsen O, Vastrup P, Andersson S, Aaby P. Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau. AIDS 2003; 17(2): 241-53.

  640. Gustafson P. Epidemiological aspects of tuberculosis in Guinea-Bissau, West Africa. Lund, Sweden: lund University; 2003.

  641. Garly ML, Aaby P. The challenge of improving the efficacy of measles vaccine. Acta Tropica 2003; 85(1): 1-17.

  642. Garly ML, Martins CL, Bale C, Balde MA, Hedegaard KL, Gustafson P, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 2003; 21(21-22): 2782-90.

  643. Fischer TK, Page AN, Griffin DD, Eugen-Olsen J, Pedersen AG, Steinsland H, et al. In-depth studies of incompletely typed rotavirus strains from Guinea-Bissau. Virology 2003; 311: 125-33.

  644. Fischer TK, Gentsch JR. Rotavirus typing methods and algorithms. Rev Med Virol 2003; 13: 1-13.

  645. Fischer TK. Epidemiological studies of rotavirus infection in Guinea-Bissau, West Africa. Danish Medical Bulletin 2003; 50(2): 103-17.

  646. Campbell SJ, Sabeti P, Fielding K, Sillah J, Bah B, Gustafson P, et al. Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa. Immunogenetics 2003; 55(7): 502-7.

  647. Benn CS, Benfeldt E, Andersen PK, Olesen AB, Melbye M, Björkstén B. Atopic Dermatitis in Young Children: Diagnostic Criteria for Use in Epidemiological Studies Based on Telephone Interviews. Acta Dermato-Venereologica 2003; 83(5): 347-50.

  648. Benn CS, Bale C, Sommerfelt H, Friis H, Aaby P. Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? International Journal of Epidemiology 2003; 32(5): 822-8.

  649. Benn CS. Early life exposures and risk of allergy. Epidemiological studies based on Danish birth cohorts. Copenhagen: University of Copenhagen; 2003.

  650. Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, et al. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol 2003; 70 Suppl 1: S42-7.

  651. Bager P, Westergaard T, Rostgaard K, Nielsen N, Melbye M, Aaby P. Smallpox vaccination and risk of allergy and asthma. Journal of Allergy and Clinical Immunology 2003; 111(6): 1227-31.

  652. Bager P. Mode of delivery and risk of allergic rhinitis and asthma. Journal of Allergy and Clinical Immunology 2003; 111(1): 51-6.

  653. Ariyoshi K, Berry N, Cham F, Jaffar S, Schim van der Loeff M, Jobe O, et al. Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality. Journal of Infectious Diseases 2003; 188(11): 1648-51.

  654. Aaby P, Simondon F, Samb B, Cisse B, Jensen H, Lisse IM, et al. Low mortality after mild measles infection compared to uninfected children in rural West Africa. Vaccine 2002; 21(1-2): 120-6.

  655. Aaby P, Marx C, Trautner S, Rudaa D, Hasselbalch H, Jensen H, et al. Thymus size at birth is associated with infant mortality: a community study from Guinea-Bissau. Acta Paediatr 2002; 91(6): 698-703.

  656. Aaby P, Jensen H, Garly ML, Bale C, Martins C, Lisse I. Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine 2002; 21(1-2): 15-20.

  657. Aaby P, Jensen H. Routine vaccinations and child survival: effect of gender. BMJ 2002; 321(7274): 1435.

  658. Tin H. O benefício do fracasso: PAM, ajuda alimentar e sobrevivencia na Guiné-Bissau, 1998- 1999. Soronda Revista de Estudos Guineenses 2002; (Nova Serie no 3): 77-145.

  659. Stensballe LG, Trautner S, Kofoed PE, Nante E, Hedegaard K, Jensen IP, et al. Comparison of nasopharyngeal aspirate and nasal swab specimens for detection of respiratory syncytial virus in different settings in a developing country. Tropical Medicine & International Health 2002; 7(4): 317-21.

  660. Stensballe L. An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark. Respiratory Research 2002; 3(Suppl 1): S34 - S9.

  661. Steinsland H, Valentiner-Branth P, Perch M, Dias F, Fischer TK, Aaby P, et al. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. Journal of Infectious Diseases 2002; 186(12): 1740-7.

  662. SSI. Respiratorisk syncytial virus. Epi Nyt 2002; Uge 24.

  663. Sodemann M, Jensen H, Rodrigues A, Ca T, Aaby P. Bandim DSS, Guinea-Bissau.  Population and health in developing countries. In: Network I, ed. Population, health, and survival at Indepth Sites. Ottawa: International Development  Research Centre; 2002: 257-62.

  664. Seng R, Gustafson P, Gomes VF, Vieira CS, Rabna P, Larsen O, et al. Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis. AIDS 2002; 16(7): 1059-66.

  665. Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, et al. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. Journal of Infectious Diseases 2002; 186(7): 888-94.

  666. Poulsen A, Qureshi K, Lisse I, Kofoed PE, Nielsen J, Vestergaard BF, et al. A household study of chickenpox in Guinea-Bissau: intensity of exposure is a determinant of severity. Journal of Infectious Diseases 2002; 45(4): 237-42.

  667. Ota M, Vekemans J, Schlegel S, Fielding K, Kidd M, Newport M, et al. Neonatal immunisation with Mycobacterium bovis bacillus Calmette-Guérin promotes immune responses to unrelated vaccine antigens. J Immunol 2002; 168: 919-25.

  668. Nielsen NR, Jensen MK. Alcohol and birth weight in Bissau, Guinea-Bissau. Copenhagen: University of Copenhagen; 2002.

  669. Nielsen NM, Aaby P, Wohlfahrt J, Molbak K, Melbye M. The polio model. Does it apply to polio? International Journal of Epidemiology 2002; 31(1): 181-6.

  670. Nielsen NM, Wohlfahrt J, Melbye M, Molbak K, Aaby P. Does cross-sex transmission increase the severity of polio infection? A study of multiple family cases. Scandinavian Journal of Infectious Diseases 2002; 34(4): 273-7.

  671. Nielsen NM, Rostgaard K, Hjalgrim H, Aaby P, Askgaard D. Poliomyelitis and Parkinson disease. JAMA 2002; 287(13): 1650-1.

  672. NIelsen AM. Poliomyelitis - statusartikel. Ugeskrift for læger, 2002.

  673. Martins CL. Nìveis de anticorpos contra o sarampo entre as mulheres em idade fertile na populacão da Guinè-Bissau expostas a sarampo natural e a imunizacão contra sarampo. Osvaldo Cruz 2002.

  674. Lienhardt C, Bennett S, Del Prete G, Bah-Sow O, Newport M, Gustafson P, et al. Investigation of Environmental and Host-related Risk Factors for Tuberculosis in Africa. I. Methodological Aspects of a Combined Design. American Journal of Epidemiology 2002; 155(11): 1066-73.

  675. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. European Journal of Immunology 2002; 32(6): 1605-13.

  676. Kofoed PE, Lopez F, Johansson P, Sandstrom A, Hedegaard K, Aaby P, et al. Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau. American Journal of Tropical Medicine and Hygiene 2002; 67(1): 28-31.

  677. Kofoed PE, Co F, Poulsen A, Cabral C, Hedegaard K, Aaby P, et al. Treatment of Plasmodium falciparum malaria with quinine in children in Guinea-Bissau: one daily dose is sufficient. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002; 96(2): 185-8.

  678. Kofoed PE, Co F, Johansson P, Dias F, Cabral C, Hedegaard K, et al. Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002; 96(3): 304-9.

  679. Jespersen SB. In search of recognition: a study of war veterans in Guinea-Bissau Copenhagen: University of Copenhagen; 2002.

  680. Jensen H. Analysis of multivariate survival data from longitudinal epidemiological studies. With special reference to the impact of routine immunizations in infancy. Copenhagen: University of Copenhagen; 2002.

  681. Jacobsen MS, Kæstel P, Cá T, Rodrigues A, Aaby P. Sexual habits and behaviour among adolescents in Bissau - results from a study of reproductive health. Bissau: Bandim Health Project, Republic of Guinea-Bissau, April 2002, 2002.

  682. Høj L. Mortalidade materna na Guiné-Bissau (Mødredødelighed i Guinea-Bissau. Størrelse, årsager og risikofaktorer). Aarhus: University of Aarhus; 2002.

  683. Holmgren B, Andersson S, Harding E, Schim van der Loeff M, Vastrup P, Aaby P, et al. Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau. Journal of Acquired Immune Deficiency Syndromes 2002; 30(3): 342-50.

  684. Holmgren B. Age and gender patterns of HIV-1, HIV-2, and HTLV-1 in Guinea-Bissau. Copenhagen: University of Copenhagen; 2002.

  685. Hoj L, da Silva D, Hedegaard K, Sandstrom A, Aaby P. Factors associated with maternal mortality in rural Guinea-Bissau. A longitudinal population-based study. BJOG: An International Journal of Obstetrics and Gynaecology 2002; 109(7): 792-9.

  686. Flanding M. Experiences of war Institute of Anthropology. Copenhagen: University of Copenhagen; 2002.

  687. Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, et al. Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa. Journal of Infectious Diseases 2002; 186(5): 593-7.

  688. Fischer TK, Steinsland H, Valentiner-Branth P. Rotavirus Particles Can Survive Storage in Ambient Tropical Temperatures for More than 2 Months. Journal of Clinical Microbiology 2002; 40(12): 4763-4.

  689. Fischer T. Epidemiological studies of rotavirus infections in Guinea-Bissau, West Africa. Bergen: Bergen University; 2002.

  690. Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. International Journal of Tuberculosis and Lung Disease 2002; 6(8): 686-92.

  691. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, N'Gom PT, et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Research and Human Retroviruses 2002; 18(16): 1167-73.

  692. Bennett S, Lienhardt C, Bah-Sow O, Gustafson P, Manneh K, Del Prete G, et al. Investigation of Environmental and Host-related Risk Factors for Tuberculosis in Africa. II. Investigation of Host Genetic Factors. American Journal of Epidemiology 2002; 155(11): 1074-9.

  693. Benn CS, Bendixen M, Krause TG, Olesen AB. Questionable coexistence of TH1- and TH2-related diseases. Journal of Allergy and Clinical Immunology 2002; 110(2): 328-9.

  694. Benn CS, Balde A, George E, Kidd M, Whittle H, Lisse IM, et al. Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. Lancet 2002; 359(9314): 1313-4.

  695. Benn C. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. Journal of Allergy and Clinical Immunology 2002; 110(1): 72-7.

  696. Aaby P, Whittle H, Cisse B, Samb B, Jensen H, Simondon F. The frailty hypothesis revisited: mainly weak children die of measles. Vaccine 2001; 20(5-6): 949-53.

  697. Aaby P, Jensen H. Authors' response. BMJ letter 2001.

  698. Aaby P, Jensen H. Response to WHO. BMJ letter 2001.

  699. Aaby P, Jensen H. Non-specific effects of vaccinations: lacking gradient, strength, and coherence? . MBJ letter 2001.

  700. Aaby P, Jensen H. Routine vaccination and child survival in Guinea-Bissau. Author's reply to commentary. BMJ 2001; 322(7282): 360.

  701. Valentiner-Branth P, Steinsland H, Santos G, Perch M, Begtrup K, Bhan MK, et al. Community-based controlled trial of dietary management of children with persistent diarrhea: sustained beneficial effect on ponderal and linear growth. Am J Clin Nutr 2001; 73(5): 968-74.

  702. Schim van der Loeff MF, Aaby P, Aryioshi K, Vincent T, Awasana AA, Da Costa C, et al. HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. AIDS 2001; 15(17): 2303-10.

  703. Rodrigues A. The pattern of cholera disease in Guinea-Bissau: Risk factors and local preventive measures. Copenhagen: University of Copenhagen; 2001.

  704. Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, et al. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. Aids 2001; 15(2): 215-22.

  705. Perch M, Sodemann M, Jakobsen MS, Valentiner-Branth P, Steinsland H, Fischer TK, et al. Seven years' experience with Cryptosporidium parvum in Guinea-Bissau, West Africa. Ann Trop Paediatr 2001; 21(4): 313-8.

  706. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, et al. The Danish National Birth Cohort--its background, structure and aim. Scand J Public Health 2001; 29(4): 300-7.

  707. Nielsen NM, Aaby P, Wohlfahrt J, Pedersen JB, Melbye M, Molbak K. Intensive exposure as a risk factor for severe polio: a study of multiple family cases. Scandinavian Journal of Infectious Diseases 2001; 33(4): 301-5.

  708. Nielsen NM, Wohlfahrt J, Aaby P, Hjalgrim H, Pedersen CB, Askgaard DS, et al. Cancer risk in a cohort of polio patients. Int J Cancer 2001; 92(4): 605-8.

  709. Nielsen NM, Hedegaard K, Aaby P. Intensity of exposure and severity of whooping cough. J Infect 2001; 43(3): 177-81.

  710. Gustafson P, Gomes VF, Vieira CS, Jensen H, Seng R, Norberg R, et al. Tuberculosis mortality during a civil war in Guinea-Bissau. Jama-Journal of the American Medical Association 2001; 286(5): 599-603.

  711. Garly ML, Bale C, Martins CL, Monteiro M, George E, Kidd M, et al. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine. Vaccine 2001; 19(15-16): 1951-9.

  712. Garly ML, Bale C, Martins CL, Balde MA, Hedegaard KL, Whittle HC, et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 2001; 20(3-4): 468-74.

  713. Cisse B. Measles antibody levels among women of fertile age and decay of maternal antibodies in a West African population exposed to natural measles and measles immunisation. London: London School of Hygiene and Tropical Medicine; 2001.

  714. Benn CS, Jeppesen DL, Hasselbalch H, Olesen AB, Nielsen J, Bjorksten B, et al. Thymus size and head circumference at birth and the development of allergic diseases. Clinical <html_ent glyph="@amp;" ascii="&amp;"/> Experimental Allergy 2001; 31(12): 1862-6.

  715. Benn CS, Bager P, Lisse I, Jensen H, Aaby P. Measles and atopy--rash on rash? Allergy 2001; 56(8): 800-1.

  716. Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall AJ, Shiell AW, et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000; 30(5): 644-50.

  717. Winqvist N, Naucler A, Gomes V, Djamanca I, Koivula T, Jensen H, et al. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa. International Journal of Tuberculosis and Lung Disease 2000; 4(9): 845-52.

  718. Whittle H, Aaby P. Measles. In: JGG L, DA W, eds. Concise Oxford Textbook of Medicine, 3rd edition. Oxford: Oxford University Press; 2000: 1517-21.

  719. Stensballe LG, Kofoed PE, Nante EJ, Sambo M, Jensen IP, Aaby P. Duration of secretory IgM and IgA antibodies to respiratory syncytial virus in a community study in Guinea-Bissau. Acta Paediatr 2000; 89(4): 421-6.

  720. Shann F, Aaby P. Unexpected beneficial effects of measles immunisation. BMJ 2000; 320(938-40).

  721. Shann F, Aaby P. Measles immunisation and confounding. BMJ 2000.

  722. Rodrigues A, Sandstrom A, Ca T, Steinsland H, Jensen H, Aaby P. Protection from cholera by adding lime juice to food - results from community and laboratory studies in Guinea-Bissau, West Africa. Tropical Medicine & International Health 2000; 5(6): 418-22.

  723. Poulsen AG, Aaby P, Jensen H, Dias F. Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scandinavian Journal of Infectious Diseases 2000; 32(2): 169-75.

  724. Nielsen NM, Wohlfahrt J, Melbye M, Rasmussen S, Molbak K, Askgaard DS, et al. Multiple sclerosis and poliomyelitis. A Danish historical cohort study. Acta Neurol Scand 2000; 101(6): 384-7.

  725. Mølbak K, Fischer Perch TK, Mikkelsen CS. The estimation of mortality due to rotavirus infections in sub-Saharan Africa. Vaccine 2000; 19(4-5): 393-5.

  726. Mølbak K. The epidemiology of diarrhoeal diseases in early childhood - A review of community studies in Guinea-Bissau. Danish Medical Bulletin 2000; 47(5): 340-58.

  727. Mølbak K. The epidemiology of diarrhoeal diseases in early childhood. A review of  community studies in Guinea-Bissau. Copenhagen: University of Copenhagen; 2000.

  728. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000; 321(7274): 1435-8.

  729. Hosp M, Lisse IM, Quigley M, Mwinga AM, Godfrey-Faussett P, Porter JD, et al. An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med 2000; 1(2): 125-7.

  730. Fischer TK, Steinsland H, Molbak K, Ca R, Gentsch JR, Valentiner-Branth P, et al. Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa. J Clin Microbiol 2000; 38(1): 264-7.

  731. Dalsgaard A, Forslund A, Petersen A, Brown DJ, Dias F, Monteiro S, et al. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau. Journal of Clinical Microbiology 2000; 38(10): 3774-9.

  732. Benn CS, Lisse IM, Bale C, Michaelsen KF, Olsen J, Hedegaard K, et al. No strong long-term effect of vitamin A supplementation in infancy on CD4 and CD8 T-cell subsets. A community study from Guinea-Bissau, West Africa. Ann Trop Paediatr 2000; 20(4): 259-64.

  733. Aaby P, Gomes J, Fernandes M, Djana Q, Lisse I, Jensen H. Nutritional status and mortality of refugee and resident children in a non-camp setting during conflict: follow up study in Guinea-Bissau. BMJ 1999; 319(7214): 878-81.

  734. Aaby P, Cisse B, Simondon F, Samb B, Soumare M, Whittle H. Waning of vaccine-induced immunity: is it a problem in Africa? American Journal of Epidemiology 1999; 149(4): 304-5.

  735. Aaby P. Forskning i International Sundhed: Lokal forankring og internationale konsekvenser eller omvendt. . In: D A, B H, P R, G A, E B, M H, eds. Sundhedsvidenskabelig Forskning. København: FADL; 1999: 645-59.

  736. Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999; 353(9147): 98-102.

  737. Whittle H, Aaby P, Samb B, Cisse B, Kanteh F, Soumaré M, et al. Serological responses 5-7 years after immunization with high titre measles vaccines in early infancy. Pediatr Infect Dis J 1999; 18: 53-7.

  738. Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999; 281(12): 1099-105.

  739. Valentiner-Branth P, Steinsland H, Gjessing HK, Santos G, Bhan MK, Dias F, et al. Community-based randomized controlled trial of reduced osmolarity oral rehydration solution in acute childhood diarrhea. Pediatric Infectious Disease Journal 1999; 18(9): 789-95.

  740. Valentinerbranth P. Diarrhoea in early childhood: Control, management and long-term consequences. Community studies from Guinea-Bissau. Copenhagen: University of Copenhagen; 1999.

  741. Sodemann M, Martins C, Mølbak K, Aaby P, Jakobsen MS. Management of childhood diarrhea and use of oral rehydration salts in a suburban West African community. The American Journal of Tropical Medicine and Hygiene 1999; 60(1): 167-71.

  742. Sodemann M, Jakobsen MS, Molbak K, Martins C, Aaby P. Episode-specific risk factors for progression of acute diarrhoea to persistent diarrhoea in west African children. Transactions of the Royal Society of Tropical Medicine and Hygiene 1999; 93(1): 65-8.

  743. Sodemann M, Jakobsen MS, Molbak K, Alvarenga IC, Martins C, Aaby P. Malaria parasitemia and childhood diarrhea in a peri-urban area of Guinea-Bissau. American Journal of Tropical Medicine and Hygiene 1999; 61(2): 336-8.

  744. Seng R, Samb B, Simondon F, Cisse B, Soumare M, Jensen H, et al. Increased long term mortality associated with rash after early measles vaccination in rural Senegal. Pediatric Infectious Disease Journal 1999; 18(1): 48-52.

  745. Schim van der Loeff MF, Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS 1999; 13 Suppl A: S69-84.

  746. Read AF, Aaby P, Antia R, Ebert D, Ewald PW, Gupta S, et al. What can evolutionary biology contribute to understanding virulence? . In: S S, ed. Evolution in Health and disease: Oxford University press; 1999: 205-15.

  747. Perch M. Cryptosporidium parvum. Incidence and mortality in childhood. A community study from Bissau, West Africa. OSVAL II 1999.

  748. Nielsen NM. Determinants of acute severity and long-term consequences of poliemylitis infection. Copenhagen: University of Copenhagen; 1999.

  749. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999; 163(4): 2249-55.

  750. Lyamuya EF, Matee MI, Aaby P, Scheutz F. Serum levels of measles IgG antibody activity in children under 5 years in Dar-es-Salaam, Tanzania. Ann Trop Paediatr 1999; 19(2): 175-83.

  751. Kofoed PE, Lopes F, Johansson P, Dias F, Sandstrom A, Aaby P, et al. Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene 1999; 93(5): 547-9.

  752. Holmgren B, Aaby P, Jensen H, Larsen O, da Silva Z, Lisse IM. Increased prevalence of retrovirus infections among older women in Africa. Scandinavian Journal of Infectious Diseases 1999; 31(5): 459-66.

  753. Hoj L, Stensballe J, Aaby P. Maternal mortality in Guinea-Bissau: the use of verbal autopsy in a multi-ethnic population. International Journal of Epidemiology 1999; 28(1): 70-6.

  754. Garly ML, Martins CL, Bale C, da Costa F, Dias F, Whittle H, et al. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. International Journal of Epidemiology 1999; 28(2): 347-52.

  755. Garly ML. Specific and non-specific effects of standard-titre measles vaccine and the BCG vaccine. Implications for the Expanded Programme on Immunizations. Copenhagen: University of Copenhagen; 1999.

  756. Cisse B, Aaby P, Simondon F, Samb B, Soumare M, Whittle H. Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. American Journal of Epidemiology 1999; 149(4): 295-301.

  757. Buckner M. Village women as town prostitutes: cultural factors relevant to prostitution and HIV epidemiology in Guinea-Bissau. In: C B, JP D, C O, M T, eds. Vivre et penser la sida en Afrique. Paris: Karthala; 1999: 389-404.

  758. Bennett J, Whittle H, Samb B, Cisse B, Simondon F, Aaby P. Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal. International Journal of Epidemiology 1999; 28(1): 147-51.

  759. Aaby P, Martins C, Bale C, Lisse I. Assessing measles vaccination coverage by maternal recall in Guinea-Bissau. Lancet 1998; 352(9135): 1229.

  760. Aaby P. Are Men Weaker or Do Their Sisters Talk too Much? Sex differences in childhood mortality and the construction of ‘biological’ differences. In: Basu AM, Aaby P, eds. The Methods and Uses of Anthropological Demography. Oxford: Clarendon Press; 1998: 223-45.

  761. Stensballe J. Hvorfor studere kvindedødsfald? OSVAL II 1998.

  762. Pison G, Aaby P. Pourquoi la rougeole tue encore en Afrique. Pour la Sicence 1998: 40-7.

  763. Nielsen LL, Nielsen NM, Melbye M, Sodermann M, Jacobsen M, Aaby P. Exposure to measles in utero and Crohn's disease: Danish register study. BMJ 1998; 316(7126): 196-7.

  764. Melbye M, Poulsen AG, Gallo D, Pedersen JB, Biggar RJ, Larsen O, et al. HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer 1998; 76(3): 293-8.

  765. Lisse I, Samb B, Whittle H, Jensen H, Soumare M, Simondon F, et al. Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scandinavian Journal of Infectious Diseases 1998; 30(1): 17-21.

  766. Larsen O, da Silva Z, Sandstrom A, Andersen PK, Andersson S, Poulsen AG, et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 1998; 12(13): 1707-14.

  767. Larsen O. Epidemiology of retroviral infections in Guinea-Bissau. Cross-sectional and longitudinal community studies. Copenhagen: University of Copenhagen; 1998.

  768. Kofoed PEL, Dias F, Lopes F, Rombo L. Diagnosis of fever in Africa. Lancet 1998; 351: 373.

  769. Grassly NC, Xiang Z, Ariyoshi K, Aaby P, Jensen H, Schim van der Loeff M, et al. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. Journal of Virology 1998; 72(10): 7895-9.

  770. Cissé B, Simondon F, Aaby P, Rougeole, Delaunay V. La situation démographique et épidémiologique dans la zone de Niakhar au Sénégal 1984-1996. Dakar, ORSTOM 1998: 91-6.

  771. Basu AM, Aaby P. The Methods and Uses of Anthropological Demography; 1998.

  772. Basu AM, Aaby P. Introduction. In: AM B, P A, eds. The Methods and Uses of Anthropological Demography. Oxford: Oxford University Press; 1998: 1-21.

  773. Aaby P, Poulsen AG, Larsen O, Christiansen CB, Jensen H, Melbye M, et al. Does HIV-2 protect against HIV-1 infection? AIDS 1997; 11(7): 939-40.

  774. Aaby P, Babiker A, Darbyshire J, Nunn A, Barreto S, Alonso P, et al. Ethics of HIV trials. Lancet 1997; 350(9090): 1546.

  775. Aaby P. An unplanned longitudinal study. In: Gupta MD, P A, G P, M G, eds. Prospective community studies in developing countries. Oxford, Clarendon press: Oxford University Press; 1997: 276-96.

  776. Sodemann M, Jakobsen MS, Molbak K, Alvarenga IC, Jr., Aaby P. High mortality despite good care-seeking behaviour: a community study of childhood deaths in Guinea-Bissau. Bulletin of the World Health Organization 1997; 75(3): 205-12.

  777. Simondon F, Preziosi M-P, Yam A, Kane CT, Chabirand L, Iteman I, et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997; 15(15): 1606-12.

  778. Samb B, Aaby P, Whittle H, Seck AM, Simondon F. Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal. American Journal of Epidemiology 1997; 145(1): 51-7.

  779. Rodrigues A, Brun H, Sandstrom A. Risk factors for cholera infection in the initial phase of an epidemic in Guinea-Bissau: protection by lime juice. American Journal of Tropical Medicine and Hygiene 1997; 57(5): 601-4.

  780. Qureshi K. Amning beskytter mod udvikling af kolera. OSVAL II 1997.

  781. Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, Lisse IM, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997; 349(9056): 911-4.

  782. Norrgren H, Marquina S, Leitner T, Aaby P, Melbye M, Poulsen AG, et al. HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997; 16(1): 31-8.

  783. Nielsen LW. Betydningen af prænatal mæslingeinfektion for udviklingen af Mb. Crohn - et historisk prospektivt studie. OSVAL II 1997.

  784. Morley DC, Aaby P. Managing measles. Size of infecting dose may be important. BMJ 1997; 314(7095): 1692; author reply -3.

  785. Molbak K, Jensen H, Ingholt L, Aaby P. Risk factors for diarrheal disease incidence in early childhood: a community cohort study from Guinea-Bissau. American Journal of Epidemiology 1997; 146(3): 273-82.

  786. Molbak K, Jakobsen M, Sodemann M, Aaby P. Is malnutrition associated with prolonged breastfeeding? International Journal of Epidemiology 1997; 26(2): 458-9.

  787. Molbak K, Andersen M, Aaby P, Hojlyng N, Jakobsen M, Sodemann M, et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr 1997; 65(1): 149-52.

  788. Melbye M, Wohlfahrt J, Westergaard T, Jensen AK, Koch A, Hjalgrim H, et al. Births at Christmas are different: population based survey of 2 million deliveries. Christmas Paper Study Group. BMJ 1997; 315(7123): 1654-5.

  789. Marx CE. Ultralydsundersøgelse af thymus hos en gruppe nyf¢dte b¢rn i Guinea-Bissau, Vestafrika. OSVAL II 1997.

  790. Lisse IM, Aaby P, Whittle H, Jensen H, Engelmann M, Christensen LB. T-lymphocyte subsets in West African children: impact of age, sex, and season. Journal of Pediatrics 1997; 130(1): 77-85.

  791. Lisse IM, Bottiger B, Christensen LB, Knudsen K, Aaby P, Gottschau A, et al. Evaluation of T cell subsets by an immunocytochemical method compared to flow cytometry in four countries. Scandinavian Journal of Immunology 1997; 45(6): 637-44.

  792. Kofoed PE, Mapaba E, Lopes F, Pussick F, Aaby P, Rombo L. Comparison of 3, 5 and 7 days' treatment with Quinimax(TM) for falciparum malaria in Guinea-Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997; 91(4): 462-4.

  793. Jensen IP, Thisted E, Glikmann G, Obel N, Kofoed P-E, Sambo M, et al. Secretory IgM and IgA antibodies to respiratory syncytial virus in nasopharyngeal aspirates: a diagnostic supplement to antigen detection. Clinical and Diagnostic Virology 1997; 8(3): 219-26.

  794. Holmgren B, Aaby P. Does HIV-2 infection provide natural protection against HIV-1? . SidAfrique 1997; 11-12: 32-3.

  795. Garenne M, Das Gupta M, Pison G, Aaby P. Introduction. In: Gupta MD, P A, G P, M G, eds. Prospective community studies in developing countries. Oxford, Clarendon press: Oxford University Press; 1997: 1-18.

  796. Das Gupta M, Aaby P, Pison G, Garenne M. Prospective community studies in developing countries. Oxford, Clarendon Press: Oxford University Press; 1997.

  797. Dalsgaard A, Reichert P, Mortensen HF, Sandström A, Kofoed P-E, Larsen JL, et al. Application of Lime (Citrus aurantifolia) Juice to Drinking Water and Food as a Cholera-Preventive Measure. Journal of Food Protection 1997; 60(11): 1329-33.

  798. Clauson-Kaas J, Surjadi C, Højlyng N, Baare A, Dzikus A, Jensen HA, et al. Crowding and health in Low-income settlements: Kali Anyar, Jakarta. Aldershot, Hants, Englnad: Avebury; 1997.

  799. Benn CS, Aaby PA, Bale C, Olsen J, Michaelsen KF, George N, et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet 1997; 350(9071): 101-5.

  800. Benn CS. Effective implementation of vitamin A programmes. Sight and Life Magazine 1997: 26-7.

  801. Atabani SF, Obeid OE, Chargelegue D, Aaby P, Whittle H, Steward MW. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection. Journal of Virology 1997; 71(10): 7240-5.

  802. Andersen M. Anthropometric measurements in health programmes: Epidemiological and statistical aspects. Copenhagen: University of Copenhagen; 1997.

  803. Aaby P, Samb B, Simondon F, Seck AMC, Knudsen K, Whittle H. Uspecifik, gavnlig effekt af mæslingevaccination: Analyse af dødelighedsstudier fra udviklingslandene. Ugeskrift  læger 1996; 158(594): 5944-8S.

  804. Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, et al. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 1996; 90(3): 326-30.

  805. Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, et al. Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal. Vaccine 1996; 14(3): 226-9.

  806. Aaby P, Samb B, Andersen M, Simondon F. No long-term excess mortality after measles infection: a community study from Senegal. American Journal of Epidemiology 1996; 143(10): 1035-41.

  807. Aaby P, Lisse IM, Molbak K, Knudsen K, Whittle H. No persistent T lymphocyte immunosuppression or increased mortality after measles infection: a community study from Guinea-Bissau. Pediatric Infectious Disease Journal 1996; 15(1): 39-44.

  808. Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, Wilkins A, et al. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: A community study from rural West Africa. AIDS 1996; 10(13): 1585-90.

  809. Aaby P, Andersen M, Knudsen K. Nutritional status and delayed mortality following early exposure to measles. Epidemiology and Infection 1996; 117(3): 525-31.

  810. Aaby P. Measles. In: A C, P H, M S-R, eds. An Historical Geography of a Major Human Viral Disease from Global Expansion to Local retreat, 1840- 1990

  811. Am J Epidemiol; 1996: 1082-83.

  812. Whittle H, Aaby P. Measles. In: DJ W, JGG L, DA W, eds. Oxford Textbook of Medicine. Oxford: Oxford University Press; 1996: 375-81.

  813. Sodemann M, Jakobsen MS, Mølbak K, Martins C, Aaby P. Maternal perception of cause, signs and severity of diarrhoea in a suburban West African community. Acta Paediatr 1996; 85(9): 1062-9.

  814. Sodeman M. Management of severe childhood illness in suburban West Africa, with special reference to diarrhoea. Community studies from Guinea-Bissau. Aarhus: University of Aarhus; 1996.

  815. Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, et al. Cell mediated immunity after measles in Guinea-Bissau: historical cohort study. BMJ 1996; 313(7063): 969-74.

  816. Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, et al. Measles and atopy in Guinea-Bissau. Lancet 1996; 347(9018): 1792-6.

  817. Samb B, Simondon F, Aaby P, Whittle H, Seck AM. L'utilisation systématique du cotrimoxazole (Bactrim) pour prévenir les complications infectieuses de la rougeole peut-elle diminuer sa mortalité? . Santé et Developpement 1996; 1233: 19-20.

  818. Molbak K, Lisse IM, Aaby P. T-lymphocyte subsets and prolonged diarrhea in young children from Guinea-Bissau. American Journal of Epidemiology 1996; 143(1): 79-84.

  819. Lisse IM, Poulsen AG, Aaby P, Knudsen K, Dias F. Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996; 13(4): 355-62.

  820. Knudsen KM, Aaby P, Whittle H, Rowe M, Samb B, Simondon F, et al. Child mortality following standard, medium or high titre measles immunization in West Africa. International Journal of Epidemiology 1996; 25(3): 665-73.

  821. Jakobsen MS, Sodemann M, Mølbak K, Aaby P. Reason for Termination of Breastfeeding and the Length of Breastfeeding. International Journal of Epidemiology 1996; 25(1): 115-21.

  822. Jakobsen M. Breast feeding in deveoping countries. Promotion and impact on childhealth. Community studies from Guinea-Bissau. Aarhus: University of Aarhus; 1996.

  823. Godtfredsen U. AIDS - hvis problem er det? . Jordens Folk 1996; 3: 89-91.

  824. Dalsgaard A, Mortensen HF, Molbak K, Dias F, Serichantalergs O, Echeverria P. Molecular characterization of Vibrio cholerae O1 strains isolated during cholera outbreaks in Guinea-Bissau. J Clin Microbiol 1996; 34(5): 1189-92.

  825. Clauson-Kaas J, Dzikus A, Stephens C, Høojlyng N, Aaby P. Urban health: human settlement indicators of crowding. Third World Planning Review 1996; 18(3): 349.

  826. Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, Naucler A, et al. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. Journal of Infectious Diseases 1996; 173(1): 245-8.

  827. Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995; 311(7003): 481-5.

  828. Aaby P, Pison G, Desgrees du Lou A, Andersen M. Lower mortality for female-female twins than male-male and male-female twins in rural Senegal. Epidemiology 1995; 6(4): 419-22.

  829. Aaby P, Jensen H, al e. Crowding and Health in Low-Income Settlements. Case Study Report, Bissau. Copenhagen: COWI; 1995.

  830. Aaby P. Assumptions and contradictions in measles and measles immunization research: Is measles good for something? Social Science & Medicine 1995; 41(5): 673-86.

  831. Aaby P. Measles immunization and child survival: uncontrolled experiments. In: H R, R G, T B, eds. Evaluation of the impact of health interventions. Liege, Belgium: International Union for the Scientific Study of Population (IUSSP); 1995: 11-45.

  832. Stabell C, Bale C, Dasilva AP, Olsen J, Aaby P. No Evidence of Fontanelle-Bulging Episodes after Vitamin-a Supplementation of 6-Month-Old and 9-Month-Old Infants in Guinea-Bissau. Eur J Clin Nutr 1995; 49(1): 73-4.

  833. Samb B, Aaby P, Whittle HC, Seck AM, Rahman S, Bennett J, et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatric Infectious Disease Journal 1995; 14(3): 203-9.

  834. Samb B, Whittle H, Aaby P, Seck AM, Bennett J, Markowitz L, et al. No evidence of long-term immunosuppression after high-titer Edmonstron-Zagreb measles vaccination in Senegal. Journal of Infectious Diseases 1995; 171(2): 506-8.

  835. Samb B, Simondon F, Aaby P, Whittle H, Seck AM. Prophylactic use of antibiotics and reduced case fatality in measles infection. Pediatric Infectious Disease Journal 1995; 14(8): 695-6.

  836. Mølsted H. Contextualision immunization. Balanta appropriation of preventive health measures in Guinea-Bissau. Copenhagen: University of Copenhagen; 1995.

  837. Gunnlaugsson G, Dasilva MC, Smedman L. Does Age at the Start of Breast-Feeding Influence Infantile Diarrhea Morbidity - a Case-Control Study in Periurban Guinea-Bissau. Acta Paediatr 1995; 84(4): 398-401.

  838. Gernow A, Lisse IM, Böttiger B, Christensen L, Brattegaard K. Determination of CD4+ and CD8+ lymphocytes with the cytosphere assay. A comparative study with flow cytometry and the immunoalkaline phophatase method

  839. Clin Immunol Immunopathol; 1995: 135-41.

  840. Desgrees du Lou A, Pison G, Aaby P. Role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. American Journal of Epidemiology 1995; 142(6): 643-52.

  841. Burstrom B, Aaby P, Mutie DM. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa. East African Medical Journal 1995; 72(3): 155-61.

  842. Burstrom B, Aaby P, Mutie DM. Validity of measles mortality data using hospital registers and community surveys. International Journal of Epidemiology 1995; 24(3): 625-9.

  843. Benn CS, Whittle H, Aaby P, Bale C, Michaelsen KF, Olsen J. Vitamin A and measles vaccination. Lancet 1995; 346(8973): 503-4.

  844. Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, et al. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bulletin of the World Health Organization 1994; 72(5): 761-70.

  845. Aaby P, Samb B. Severe measles and its control in developing countries. Dogmas and new perspectives. In: KS L, S B, PH M, M P, eds. Health and disease in developing countries. London: Macmillan Press; 1994: 163-76.

  846. Aaby P, Lisse IM, Whittle H, Knudsen K, Thaarup J, Poulsen A, et al. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up. Epidemiology and Infection 1994; 112(2): 413-20.

  847. Aaby P, Knudsen K, Simondon F, Samb B, Whittle H, Seck AM, et al. High-titre measles vaccines for boys. Lancet 1994; 344(8931): 1226-7.

  848. Aaby P, Andersen M, Sodemann M, Jakobsen M, Gomes J, Fernandes M. [Measles vaccination and age]. Ugeskrift for Læger 1994; 156(40): 5857-61.

  849. Samb B. Impact epidemiologique et demographique de la rougeole e de la vaccination contre la rougeole dans une zone rurale du Senegal (Niakhar) [PhD]. Paris: Universite Pierre e Marie Curie (Paris VI); 1994.

  850. Molbak K, Aaby P, Hojlyng N, da Silva AP. Risk factors for Cryptosporidium diarrhea in early childhood: a case-control study from Guinea-Bissau, West Africa. American Journal of Epidemiology 1994; 139(7): 734-40.

  851. Molbak K, Wested N, Hojlyng N, Scheutz F, Gottschau A, Aaby P, et al. The etiology of early childhood diarrhea: a community study from Guinea-Bissau. J Infect Dis 1994; 169(3): 581-7.

  852. Molbak K, Lisse IM, Hojlyng N, Aaby P. Severe cryptosporidiosis in children with normal T-cell subsets. Parasite Immunol 1994; 16(5): 275-7.

  853. Molbak K, Gottschau A, Aaby P, Hojlyng N, Ingholt L, da Silva AP. Prolonged breast feeding, diarrhoeal disease, and survival of children in Guinea-Bissau. BMJ 1994; 308(6941): 1403-6.

  854. Lisse IM, Aaby P, Whittle H, Knudsen K. A community study of T lymphocyte subsets and malaria parasitaemia. Transactions of the Royal Society of Tropical Medicine and Hygiene 1994; 88(6): 709-10.

  855. Lisse IM, Aaby P, Knudsen K, Whittle H, Andersen H. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets. Pediatric Infectious Disease Journal 1994; 13(2): 109-12.

  856. Knudsen K. Analysis of event history data in measles and diarrhea epidemiology. Copenhagen: University of Copenhagen; 1994.

  857. Jensen TG, Whittle H, Mordhorst CH, Pedersen IR, Thaarup J, Poulsen A, et al. Trials of Edmonston-Zagreb Measles-Vaccine in Guinea-Bissau - Serological Responses Following Vaccination with Edmonston-Zagreb Strain at 4-8 Months Versus Vaccination with Schwarz Strain at 9-12 Months of Age. Vaccine 1994; 12(11): 1026-31.

  858. Desgrées du Loû A. Le rôle des vaccinations dans la baisse de la mortalité des enfants en Afrique. Resultats d'une enquete longitudinale menee dans la zone rurale de bandafassi, au senegal, entre 1970 et 1993 [Thèse de doctorat en Sciences médicales]. Paris; 1994.

  859. Bennett J, Aaby P, Simondon F, Samb B, Whittle H, Seck AM, et al. Sex differences in measles fatality and Edmonston-Zagreb measles vaccine. Lancet 1994; 344(8921): 545.

  860. Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. American Journal of Epidemiology 1993; 138(9): 746-55.

  861. Aaby P, Knudsen K, Whittle H, Lisse IM, Thaarup J, Poulsen A, et al. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. Journal of Pediatrics 1993; 122(6): 904-8.

  862. Aaby P, Knudsen K, Pison G. [Higher mortality due to measles in Senegal for children with siblings of the opposite sex]. Ugeskrift for Læger 1993; 155(39): 3126-30.

  863. Aaby P, Andersen M, Sodemann M, Jakobsen M, Gomes J, Fernandes M. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ 1993; 307(6915): 1308-11.

  864. Aaby P, Andersen M, Knudsen KIM. Excess Mortality after Early Exposure to Measles. International Journal of Epidemiology 1993; 22(1): 156-62.

  865. Whittle H, Aaby P. Measles. In: Ledingham JGG, Warrell DA, eds. Concise Oxford Textbook of Medicine, 3rd edition. Oxford: Oxford University Press; 1993: 1517-21.

  866. Sodemann M. 25 historias clinicas de criancas mortas. Bissau: Projecto de Saúde de Bandim. 1993.

  867. Samb B, Aaby P, Whittle H, Seck AMC, Simondon F. Protective Efficacy of High-Titer Measles-Vaccines Administered from the Age of 5 Months - a Community Study in Rural Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993; 87(6): 697-701.

  868. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Molbak K, et al. HIV-2 infection in Bissau, West Africa, 1987-1989: incidence, prevalences, and routes of transmission. Journal of Acquired Immune Deficiency Syndromes 1993; 6(8): 941-8.

  869. Mølbak K. Dør af diarré. PUF (EF Forskning og Udvikling) 1993; 3.

  870. Molbak K, Hojlyng N, Gottschau A, Sa JC, Ingholt L, da Silva AP, et al. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. British Medical Journal 1993; 307(6901): 417-20.

  871. Lisse IM. Immuno-alkaline Phosphatase Method. An introduction to alternative methodologies for CD4 lymphocyte determinations. WHO Global programme on AIDS 1993.

  872. Lisse IM. Laboratory manual for a simple method for characterization of T cell subsets in the peripheral blood: An immuno-alkaline phosphatase method. WHO GPA 1993.

  873. Gunnlaugsson G, da Silva MC, Smedman L. Age at breast feeding start and postneonatal growth and survival. Archives of Disease in Childhood 1993; 69(1): 134-7.

  874. Burstrom B, Aaby P, Mutie DM. Child mortality impact of a measles outbreak in a partially vaccinated rural African community. Scandinavian Journal of Infectious Diseases 1993; 25(6): 763-9.

  875. Aaby P, Oesterle H, Dietz K, Becker N. Case-fatality rates in severe measles outbreak in rural Germany in 1861. Lancet 1992; 340(8828): 1172.

  876. Aaby P, Burstrom B, Mutie DM. Measles mortality in same-sex and mixed-sex siblings in Kenya. Lancet 1992; 340(8824): 923-4.

  877. Aaby P. Overcrowding and intensive exposure: major determinants of varistions in measles mortality in Africa. In: Walle Evd, Pison G, Sala-Diakanda M, eds. Mortality and society in Sub-Saharan Africa. Oxford, England: Clarendon Press; 1992: 319-48.

  878. Aaby P. Lessons for the past: Third World evidence and the reinterpretation of developed world mortality declines. Historical Epidemiology and the Health Transition 1992; Vol. 2, Supplementary issue: 155-83.

  879. Aaby P. Influence of cross-sex transmission on measles mortality in rural Senegal. Lancet 1992; 340(8816): 388-91.

  880. Aaby P. Patterns of exposure and severity of measles infection. Copenhagen 1915-1925. Ann Epidemiol 1992; 2(3): 257-62.

  881. Poulsen AG, Kvinesdal BB, Aaby P, Lisse IM, Gottschau A, Molbak K, et al. Lack of evidence of vertical transmission of human immunodeficiency virus type 2 in a sample of the general population in Bissau. Journal of Acquired Immune Deficiency Syndromes 1992; 5(1): 25-30.

  882. Pison G, Aaby P, Knudsen K. Increased risk of death from measles in children with a sibling of opposite sex in Senegal. Bmj 1992; 304(6822): 284-7.

  883. Molbak K, Aaby P, Ingholt L, Hojlyng N, Gottschau A, Andersen H, et al. Persistent and acute diarrhoea as the leading causes of child mortality in urban Guinea Bissau. Transactions of the Royal Society of Tropical Medicine and Hygiene 1992; 86(2): 216-20.

  884. Manderson L, Aaby P. An epidemic in the field? Rapid assessment procedures and health research. Soc Sci Med 1992; 35(7): 839-50.

  885. Manderson L, Aaby P. Can rapid anthropological procedures be applied to tropical diseases? Health Policy and Planning 1992; 7(1): 46-55.

  886. Kronborg D, Hansen B, Aaby P. Analysis of the incubation period for measles in the epidemic in Greenland in 1951 using a variance components model. Stat Med 1992; 11(5): 579-90.

  887. Høgsborg M, Aaby P. Sexual relations, use of condoms and perceptions of AIDS in an urban area of Guinea Bissau with a high prevalence of HIV 2. In: T D, ed. Sexual behaviour and networking: Anthropological and socio-cultural studies on the transmission of HIV. Liege, Beligum: Editions Derouax-Ordina; 1992: 203-32.

  888. Gunnlaugsson G, Dasilva MC, Smedman L. Determinants of Delayed Initiation of Breast-Feeding - a Community and Hospital Study from Guinea-Bissau. International Journal of Epidemiology 1992; 21(5): 935-40.

  889. Burstrom B, Aaby P, Mutie DM, Kimani G, Bjerregaard P. Severe measles outbreak in western Kenya. East Afr Med J 1992; 69(8): 419-23.

  890. Aaby P, Samb B, Simondon F, Whittle H, Seck AM, Knudsen K, et al. Child mortality after high-titre measles vaccines in Senegal: the complete data set. Lancet 1991; 338(8781): 1518-9.

  891. Aaby P, Leeuwenburg J. Gender and the pattern of transmission of measles infection. A reanalysis of data from the Machakos area, Kenya. Ann Trop Paediatr 1991; 11(4): 397-402.

  892. Aaby P, Lamb WH. The role of sex in the transmission of measles in a Gambian village. J Infect 1991; 22(3): 287-92.

  893. Aaby P, Clements J, Orinda V. Mortality from measles: measuring the impact.  Expanded Programme on Immunization. Geneva: WHO; 1991.

  894. Aaby P. Death houses.  Socio-Cultural determinants of morbidity and mortality in developing countries: The role of longitudinal studies; 1991; Saly Portudal, Senegal: Liège: International Union for the Scientific Study of Population (IUSSP); 1991.

  895. Aaby P. Bandim: An unplanned longitudinal study.  Seminar on Socio-Cultural determinants of morbidity and mortality in developing countries: The role of longitudinal studies; 1991; Saly Portudal, Senegal: IUSSP, Liege; 1991.

  896. Aaby P. Severity of measles and cross-sex transmission of infection in Copenhagen 1915-1925. International Journal of Epidemiology 1991; 20(2): 504-7.

  897. Aaby P. Determinants of measles mortality: Host or transmission factors? . Medical Virology 1991; (10): 83-116.

  898. Pison G, Aaby P, Desgrées du Lou A. Child mortality in Bandafassi, Senegal, 1970-1991: Increased risk of measles death for children with a sibling of the opposite sex.  Seminar on Socio-Cultural determinants of morbidity and mortality in developing countries: The role of longitudinal studies; 1991; Saly Portudal, Senegal: IUSSP, Liege; 1991.

  899. P A. The long term impact of measles infection. A new perspective. Proceedings of the 48th Session, Cairo 1991. Cairo: Bulletin of the International Statistical Institute; 1991: 369-93.

  900. Ferro A, Poulsen AG, Zanforlin M, Marigo A, Sabbatani S. Extended use of the micro-haematocrit capillary specimen in Third World blood banks. Transactions of the Royal Society of Tropical Medicine and Hygiene 1991; (85): 833.

  901. Aaby P, Seim E, Knudsen K, Bukh J, Lisse IM, da Silva MC. Increased postperinatal child mortality among children of mothers exposed to measles during pregnancy. American Journal of Epidemiology 1990; 132(3): 531-9.

  902. Aaby P, Molbak K. Siblings of opposite sex as a risk factor for child mortality. BMJ 1990; 301(6744): 143-5.

  903. Aaby P, Leeuwenburg J. Patterns of transmission and severity of measles infection: a reanalysis of data from the Machakos area, Kenya. Journal of Infectious Diseases 1990; 161(2): 171-4.

  904. Aaby P, Knudsen K, Jensen TG, Tharup J, Poulsen A, Sodemann M, et al. Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage. Journal of Infectious Diseases 1990; 162(5): 1043-8.

  905. Aaby P, Bukh J, Kronborg D, Lisse IM, da Silva MC. Delayed excess mortality after exposure to measles during the first six months of life. American Journal of Epidemiology 1990; 132(2): 211-9.

  906. Aaby P. Social and behavioral factors affecting transmission and severity of measles infection. In: Caldwell J, Findley S, P C, Santow S, Cosford W, Braid J, et al., eds. What we know about Health Transition: The cultural, social and behavioural determinants of health. Canberra: Health Transition Center; 1990: 826-42.

  907. Molbak K, Hojlyng N, Ingholt L, Da Silva AP, Jepsen S, Aaby P. An epidemic outbreak of cryptosporidiosis: a prospective community study from Guinea Bissau. Pediatric Infectious Disease Journal 1990; 9(8): 566-70.

  908. Lisse IM, Whittle H, Aaby P, Normark M, Gyhrs A, Ryder LP. Labelling of T cell subsets under field conditions in tropical countries. Adaptation of the immuno-alkaline phosphatase staining method for blood smears. J Immunol Methods 1990; 129(1): 49-53.

  909. Lisse IM, Poulsen AG, Aaby P, Normark M, Kvinesdal B, Dias F, et al. Immunodeficiency in HIV-2 infection: a community study from Guinea-Bissau. AIDS 1990; 4(12): 1263-6.

  910. Kronborg D, Aaby P. Piecewise comparison of survival functions in stratified proportional hazards models. Biometrics 1990; 46(2): 375-80.

  911. Hall AJ, Aaby P. Tropical trials and tribulations. International Journal of Epidemiology 1990; 19(4): 777-81.

  912. Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. Journal of Infectious Diseases 1990; 161(6): 1088-94.

  913. Aaby P, Pedersen IR, Knudsen K, da Silva MC, Mordhorst CH, Helm-Petersen NC, et al. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatric Infectious Disease Journal 1989; 8(4): 197-200.

  914. Aaby P, Clements CJ. Measles immunization research: a review. Bulletin of the World Health Organization 1989; 67(4): 443-8.

  915. Aaby P. Malnutrition and/vs overcrowding in child survival. Proceedings of IUSSP's International Congress, Delhi.  International Congress,. Delhi: IUSSP; 1989. p. 351-262.

  916. Aaby P. Tuhkarokko [Severe measles and its control in developing countries: Dogmas and new perspectives]. In: KS L, JT K, PH M, Peltola H, M P, eds. Kehitysmaiden terveys ja sairaus [Health and disease in developing countries]. Finland: Kandidaattikustannus Oy; 1989: 441-54.

  917. Aaby P. Malnourished or overinfected. An analysis of the determinants of acute measles mortality. Danish Medical Bulletin 1989; 36(2): 93-113.

  918. Aaby P. La promiscuité, un facteur déterminant de la mortalité par rougeole. In: Pison G, Walle Evd, Sala-Diakanda M, eds. Mortalité et Société en Afrique au sud du Sahara. Paris: Institut national d'études démographiques; 1989: 295 -324.

  919. Poulsen AG, Kvinesdal B, Aaby P, Molbak K, Frederiksen K, Dias F, et al. Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1989; 1(8642): 827-31.

  920. Kvinesdal BB, Nielsen CM, Poulsen AG, Hojlyng N. Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2. J Clin Microbiol 1989; 27(11): 2502-4.

  921. Gomes J, Fernandes MA, Indi F, Da Gama MS, Sami J, Aaby P. [Malnutrition and infant mortality in the regions of Tombali, Cacheu, Oio, Biombo, and Gabu]. Bol Inf Socio Econ 1989; 5: 11-44.

  922. Aaby P, Jensen TG, Hansen HL, Kristiansen H, Tharup J, Poulsen A, et al. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet 1988; 2(8615): 809-11.

  923. Aaby P, Bukh J, Lisse IM, Seim E, de Silva MC. Increased perinatal mortality among children of mothers exposed to measles during pregnancy. Lancet 1988; 1(8584): 516-9.

  924. Aaby P, Bukh J, Lisse IM, da Silva MC. Decline in measles mortality: nutrition, age at infection, or exposure? Br Med J (Clin Res Ed) 1988; 296(6631): 1225-8.

  925. Aaby P, Bukh J, Lisse IM, da Silva MC. Further community studies on the role of overcrowding and intensive exposure on measles mortality. Reviews of Infectious Diseases 1988; 10(2): 474-7.

  926. Aaby P. Le surpeuplement, un facteur déterminant de la mortalité par rougeole en Afrique. Dossiers et recherches, INED 1988; 15.

  927. Aaby P. Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Reviews of Infectious Diseases 1988; 10(2): 478-91.

  928. Aaby P. Severe measles in Copenhagen, 1915-1925. Reviews of Infectious Diseases 1988; 10(2): 452-6.

  929. Aaby P. Introduction to community studies of severe measles: Comparative test of the crowding/exposure hypothesis. Reviews of Infectious Diseases 1988; 10

  930. 451.

  931. Aaby P. Observing the unexpected. Nutrition and child mortality in Guinea-Bissau. In: JC C, A H, VJ H, eds. Micro approaches in demographic research. London: Keagan Poul; 1988: 278-96.

  932. Whittle H, Hanlon P, O'Neill K, Hanlon L, Marsh V, Jupp E, et al. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet 1988; 2(8615): 811-4.

  933. Smedman L, Gunnlaugsson G, Norrby E, Silva MC, Zetterstrom R. Follow-up of the antibody response to measles vaccine in a rural area of Guinea-Bissau. Acta Paediatrica Scandinavica 1988; 77(6): 885-9.

  934. Aaby P, Clements J, Cohen N. Key issues in measles immunization research: A review of the literature. WHO, EPI 1987.

  935. Aaby P, Bukh J, Hoff G, Lisse IM, Smits AJ. Humoral immunity in measles infection: a critical factor? Med Hypotheses 1987; 23(3): 287-301.

  936. Smedman L, Sterky G, Mellander L, Wall S. Anthropometry and Subsequent Mortality in Groups of Children Aged 6-59 Months in Guinea-Bissau. Am J Clin Nutr 1987; 46(2): 369-73.

  937. Aaby P, Bukh J, Lisse IM, Smits AJ, da Silva C. Determinants des formes severes de rougeole: consequences au niveau de l´action preventive. In: P C, S D, Ph F, J G, J G, Rouquette R, eds. Estimation de la Mortalité de june Enfant (0-5 ans) pour guider les Actions de Santé dans les Pays en Développement. Paris: INSERM; 1986: 429-42.

  938. Aaby P, Bukh J, Lisse IM, Smits AJ. Severe measles in Sunderland, 1885: a European-African comparison of causes of severe infection. International Journal of Epidemiology 1986; 15(1): 101-7.

  939. Aaby P, Bukh J, Leerhoy J, Lisse IM, Mordhorst CH, Pedersen IR. Vaccinated children get milder measles infection: a community study from Guinea-Bissau. Journal of Infectious Diseases 1986; 154(5): 858-63.

  940. Aaby P, Bukh J, Hoff G, Lisse IM, Smits AJ. Cross-sex transmission of infection and increased mortality due to measles. Reviews of Infectious Diseases 1986; 8(1): 138-43.

  941. Aaby P, Bukh J, Hoff G, Leerhoy J, Lisse IM, Mordhorst CH, et al. High measles mortality in infancy related to intensity of exposure. Journal of Pediatrics 1986; 109(1): 40-4.

  942. Smedman L, Aaby P, Lindeberg A, Zetterstrom R. Survival 0-6 Years of Age in a Periurban Community in Guinea-Bissau - a Longitudinal Assessment. Ann Trop Paediatr 1986; 6(1): 67-72.

  943. Smedman L, Silva MC, Gunnlaugsson G, Norrby E, Zetterstrom R. Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia. Ann Trop Paediatr 1986; 6(2): 149-53.

  944. Mølbak K, Lauritzen E, Fernandes D, Böttiger B, Biberfeld G. Antibodies to HTLV-IV associated with chronic, fatal illness resembling "slim" disease. Lancet 1986; 328(8517): 1214-5.

  945. Aaby P, Coovadia H. Severe measles: a reappraisal of the role of nutrition, overcrowding and virus dose. Med Hypotheses 1985; 18(2): 93-112.

  946. Aaby P, Bukh J, Lisse IM, Smits AJ. Introduction of measles into a highly immunised West African community: the role of health care institutions. J Epidemiol Community Health 1985; 39(2): 113-6.

  947. Aaby P. Epidemics among Amerindians and Inuits. A preliminary interpretation. In: J B, J D, A G, HC G, G H, JB J, et al., eds. Native Power. Bergen: Universitetsforlaget; 1985: 329-39.

  948. Aaby P, Bukh J, Lisse IM, Smits AJ, Gomes J, Fernandes MA, et al. Determinants of measles mortality in a rural area of Guinea-Bissau: crowding, age, and malnutrition. J Trop Pediatr 1984; 30(3): 164-8.

  949. Aaby P, Bukh J, Lisse IM, Smits AJ. Risk factors in subacute sclerosing panencephalitis: age- and sex-dependent host reactions or intensive exposure? Reviews of Infectious Diseases 1984; 6(2): 239-50.

  950. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984; 8(1): 13-21.

  951. Aaby P, Bukh J, Lisse IM, Smits AJ. Overcrowding and intensive exposure as determinants of measles mortality. American Journal of Epidemiology 1984; 120(1): 49-63.

  952. Aaby P, Bukh J, Lisse IM. Børnedødelighed i Guinea-Bissau. Ugeskr Laeger 1984; 146: 2048.

  953. Aaby P, Bukh J, Smits AJ, Lisse IM, Gomes J, Fernandes MA, et al. High case fatality rate in twins with measles. Lancet 1983; 2(8351): 690.

  954. Aaby P, Bukh J, Lisse IM, Smits AJ. Les hommes sont-ils plus faibles ou leurs soeurs parlent-elles trop? Essai sur la transmission des maladies infectieuses. Anthropologie et Sociétés 1983; 7(2): 47-59.

  955. Aaby P, Bukh J, Lisse IM, Smits AJ. Spacing, crowding, and child mortality in Guinea-Bissau. Lancet 1983; 2(8342): 161.

  956. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles mortality, state of nutrition, and family structure: a community study from Guinea-Bissau. Journal of Infectious Diseases 1983; 147(4): 693-701.

  957. Smedmann L, Lindeberg A, Jeppson O, Zetterstrom R. Measles mortality and malnutrition. Lancet 1983: 695.

  958. Smedman L, Lindeberg A, Jeppsson O, Zetterstrom R. Nutritional status and measles: a community study in Guinea-Bissau. Ann Trop Paediatr 1983; 3(4): 169-76.

  959. Aaby P, Bukh J, Lisse IM, Smits AJ, Smedman L, Jeppsson O, et al. Breastfeeding and measles mortality in Guinea-Bissau. Lancet 1981; 2(8257): 1231.

  960. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and child mortality. Lancet 1981; 2(8237): 93.

  961. Aaby P, Bukh J, Lisse IM, Smits AJ. Child mortality in Guinea-Bissau: Malnutrition or overcrowding. Swedish Agency for Research Cooperation (SAREC) 1981.

Last revised 8 November 2018